{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:43:35Z","timestamp":1793133815741,"version":"4.5.0"},"reference-count":406,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Natures Science Foundation of Nantong City","award":["JC2023041"],"award-info":[{"award-number":["JC2023041"]}]},{"name":"Postgraduate Research & Practice Innovation Program of Jiangsu Province","award":["KYCX25_3838"],"award-info":[{"award-number":["KYCX25_3838"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Sciences Foundation of China","doi-asserted-by":"crossref","award":["81970226"],"award-info":[{"award-number":["81970226"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Vascular restenosis, a pathological recurrence of lumen narrowing following interventions, remains a major limitation to the long-term success of vascular procedures. Its development is centrally driven by neointimal hyperplasia, a process orchestrated by endothelial injury, phenotypic switching of vascular smooth muscle cells (VSMCs) from a contractile to a synthetic state, and a coordinated inflammatory response. Despite advancements, the molecular mechanisms are not fully elucidated, and specific, effective pharmacotherapies are still lacking. This review systematically delineates the pathophysiology, focusing on these three core elements, and provides a comprehensive landscape of the complex signaling networks and molecular targets. We extensively cover protein-based regulators\u2014including pro-proliferative factors (e.g., LSD1, FGF10), protective mediators (e.g., CGRP, A20), dual-action molecules with isoform-specific or context-dependent effects (e.g., KLFs, HDACs), endothelial repair targets (e.g., VEGF), and molecules that coordinately target both VSMCs and endothelial cells (ECs) (e.g., PERK, METTL3). We place significant focus on non-coding RNAs, particularly microRNAs (miRNAs) like miR-221\/222, which fine-tune multiple targets in both VSMCs and ECs, offering unique precision. We critically evaluate the therapeutic significance and clinical translation potential, while addressing formidable challenges: functional duality within protein families (e.g., KLFs, HDACs), difficulties in cell-specific delivery and stability for miRNA therapies, and a narrow therapeutic window. Additionally, we highlight the emerging role of the vascular adventitia as a key source of regulatory signals (e.g., FGF10). By integrating insights from molecular mechanisms to therapeutic interventions, this work serves as a valuable reference for identifying novel strategies to combat neointima formation and vascular restenosis.<\/jats:p>","DOI":"10.1186\/s43556-026-00477-6","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T02:23:54Z","timestamp":1779675834000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Neointimal hyperplasia and vascular restenosis: from molecular mechanisms to therapeutic interventions"],"prefix":"10.1186","volume":"7","author":[{"given":"Lingyan","family":"Yi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peile","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"issue":"1","key":"477_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jacc.2015.05.002","volume":"66","author":"S Habara","year":"2015","unstructured":"Habara S, Kadota K, Shimada T, Ohya M, Amano H, Izawa Y, et al. Late Restenosis After Paclitaxel-Coated Balloon Angioplasty Occurs in Patients With Drug-Eluting Stent Restenosis. J Am Coll Cardiol. 2015;66(1):14\u201322. https:\/\/doi.org\/10.1016\/j.jacc.2015.05.002.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"477_CR2","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1007\/s00270-019-02264-z","volume":"42","author":"MC Jundt","year":"2019","unstructured":"Jundt MC, Takahashi EA, Harmsen WS, Misra S. Restenosis rates after drug-eluting stent treatment for stenotic small-diameter renal arteries. Cardiovasc Intervent Radiol. 2019;42(9):1293\u2013301. https:\/\/doi.org\/10.1007\/s00270-019-02264-z.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"15","key":"477_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202307063","volume":"11","author":"C Fu","year":"2024","unstructured":"Fu C, Li Q, Li M, Zhang J, Zhou F, Li Z, et al. An integrated arterial remodeling hydrogel for preventing restenosis after angioplasty. Adv Sci (Weinheim, Baden-Wurttemberg, Germany). 2024;11(15):e2307063. https:\/\/doi.org\/10.1002\/advs.202307063.","journal-title":"Adv Sci (Weinheim, Baden-Wurttemberg, Germany)"},{"issue":"2","key":"477_CR4","first-page":"1494","volume":"15","author":"Y Yang","year":"2023","unstructured":"Yang Y, Chen S, Yan Z, Jiao Y. Clinical advantage of drug-coated balloon in treatment of restenosis in superficial femoral artery stents. Am J Transl Res. 2023;15(2):1494\u2013501.","journal-title":"Am J Transl Res"},{"issue":"2","key":"477_CR5","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3109\/07853899409147335","volume":"26","author":"ST Nikkari","year":"1994","unstructured":"Nikkari ST, Clowes AW. Restenosis after vascular reconstruction. Ann Med. 1994;26(2):95\u2013100. https:\/\/doi.org\/10.3109\/07853899409147335.","journal-title":"Ann Med"},{"issue":"2","key":"477_CR6","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1097\/imi.0000000000000130","volume":"10","author":"RW Emery","year":"2015","unstructured":"Emery RW, Solien E, Puskas JD. Implantation of the eSVS mesh: modification of recommended technique. Innovations. 2015;10(2):146\u20139. https:\/\/doi.org\/10.1097\/imi.0000000000000130.","journal-title":"Innovations"},{"key":"477_CR7","doi-asserted-by":"publisher","DOI":"10.1177\/20417314251315959","volume":"16","author":"Y Ye","year":"2025","unstructured":"Ye Y, Huang L, Wang K, Sun Y, Zhou Z, Deng T, et al. Transplantation of engineered endothelial progenitor cells with H19 overexpression promotes arterial reendothelialization and inhibits neointimal hyperplasia. J Tissue Eng. 2025;16:20417314251315959. https:\/\/doi.org\/10.1177\/20417314251315959.","journal-title":"J Tissue Eng"},{"issue":"17","key":"477_CR8","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1093\/eurheartj\/ehae911","volume":"46","author":"Q Zhang","year":"2025","unstructured":"Zhang Q, Li H, Zhuang T, Xu L, Wu W, Pi J, et al. CCN5 suppresses injury-induced vascular restenosis by inhibiting smooth muscle cell proliferation and facilitating endothelial repair via thymosin \u03b24 and Cd9 pathway. Eur Heart J. 2025;46(17):1645\u201358. https:\/\/doi.org\/10.1093\/eurheartj\/ehae911.","journal-title":"Eur Heart J"},{"issue":"3","key":"477_CR9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1515\/prilozi-2015-0077","volume":"36","author":"V Pushevski","year":"2015","unstructured":"Pushevski V, Dejanov P, Gerasimovska V, Petrushevska G, Oncevski A, Sikole A, et al. Severe endothelial damage in chronic kidney disease patients prior to haemodialysis vascular access surgery. Prilozi. 2015;36(3):43\u20139. https:\/\/doi.org\/10.1515\/prilozi-2015-0077.","journal-title":"Prilozi"},{"issue":"1","key":"477_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4174\/astr.2017.93.1.11","volume":"93","author":"JH Ryu","year":"2017","unstructured":"Ryu JH, Park H, Kim SJ. The effects of indoxyl sulfate-induced endothelial microparticles on neointimal hyperplasia formation in an ex vivo model. Ann Surg Treat Res. 2017;93(1):11\u20137. https:\/\/doi.org\/10.4174\/astr.2017.93.1.11.","journal-title":"Ann Surg Treat Res"},{"key":"477_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1581681","volume":"16","author":"J Hubska","year":"2025","unstructured":"Hubska J, Roszkowska Z, Bobrowicz M, Iwaniuk S, Rak-Makowska B, Ambroziak U. Endothelial dysfunction in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: current knowledge and novel biomarkers. Front Endocrinol. 2025;16:1581681. https:\/\/doi.org\/10.3389\/fendo.2025.1581681.","journal-title":"Front Endocrinol"},{"issue":"2","key":"477_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70057","volume":"6","author":"T Xia","year":"2025","unstructured":"Xia T, Yu J, Du M, Chen X, Wang C, Li R. Vascular endothelial cell injury: causes, molecular mechanisms, and treatments. MedComm. 2025;6(2):e70057. https:\/\/doi.org\/10.1002\/mco2.70057.","journal-title":"MedComm"},{"key":"477_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26115355","author":"K Backston","year":"2025","unstructured":"Backston K, Morgan J, Patel S, Koka R, Hu J, Raina R. Oxidative stress and endothelial dysfunction: the pathogenesis of pediatric hypertension. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26115355.","journal-title":"Int J Mol Sci"},{"key":"477_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/md23040154","author":"A Covaciu","year":"2025","unstructured":"Covaciu A, Benedek T, Bobescu E, Rus H, Benza V, Marceanu LG, et al. Polyunsaturated fatty acids improved long term prognosis by reducing oxidative stress, inflammation, and endothelial dysfunction in acute coronary syndromes. Mar Drugs. 2025. https:\/\/doi.org\/10.3390\/md23040154.","journal-title":"Mar Drugs"},{"key":"477_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26083660","author":"H Abrashev","year":"2025","unstructured":"Abrashev H, Abrasheva D, Nikolov N, Ananiev J, Georgieva E. A systematic review of endothelial dysfunction in chronic venous disease-inflammation, oxidative stress, and shear stress. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26083660.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"477_CR16","doi-asserted-by":"publisher","DOI":"10.31083\/j.fbl2703105","volume":"27","author":"A Shaito","year":"2022","unstructured":"Shaito A, Aramouni K, Assaf R, Parenti A, Orekhov A, Yazbi AE, et al. Oxidative stress-induced endothelial dysfunction in cardiovascular diseases. Front Biosci (Landmark edition). 2022;27(3):105. https:\/\/doi.org\/10.31083\/j.fbl2703105.","journal-title":"Front Biosci (Landmark edition)"},{"issue":"Pt B","key":"477_CR17","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.yjmcc.2015.01.021","volume":"89","author":"AJ Donato","year":"2015","unstructured":"Donato AJ, Morgan RG, Walker AE, Lesniewski LA. Cellular and molecular biology of aging endothelial cells. J Mol Cell Cardiol. 2015;89(Pt B):122\u201335. https:\/\/doi.org\/10.1016\/j.yjmcc.2015.01.021.","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"477_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-01965-7","volume":"22","author":"Y An","year":"2023","unstructured":"An Y, Xu BT, Wan SR, Ma XM, Long Y, Xu Y, et al. The role of oxidative stress in diabetes mellitus-induced vascular endothelial dysfunction. Cardiovasc Diabetol. 2023;22(1):237. https:\/\/doi.org\/10.1186\/s12933-023-01965-7.","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"477_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/fsn3.70254","volume":"13","author":"Y Pan","year":"2025","unstructured":"Pan Y, Xia M, Luo J, Lu S. Resveratrol promotes wound healing by enhancing angiogenesis via inhibition of ferroptosis. Food Sci Nutr. 2025;13(5):e70254. https:\/\/doi.org\/10.1002\/fsn3.70254.","journal-title":"Food Sci Nutr"},{"issue":"1","key":"477_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s13020-025-01064-7","volume":"20","author":"Y Bai","year":"2025","unstructured":"Bai Y, Tan D, Deng Q, Miao L, Wang Y, Zhou Y, et al. Cinnamic acid alleviates endothelial dysfunction and oxidative stress by targeting PPAR\u03b4 in obesity and diabetes. Chin Med. 2025;20(1):13. https:\/\/doi.org\/10.1186\/s13020-025-01064-7.","journal-title":"Chin Med"},{"issue":"4","key":"477_CR21","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s10456-024-09938-4","volume":"27","author":"B Pang","year":"2024","unstructured":"Pang B, Dong G, Pang T, Sun X, Liu X, Nie Y, et al. Emerging insights into the pathogenesis and therapeutic strategies for vascular endothelial injury-associated diseases: focus on mitochondrial dysfunction. Angiogenesis. 2024;27(4):623\u201339. https:\/\/doi.org\/10.1007\/s10456-024-09938-4.","journal-title":"Angiogenesis"},{"issue":"8","key":"477_CR22","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1007\/s11010-023-04835-8","volume":"479","author":"SK Prajapat","year":"2024","unstructured":"Prajapat SK, Maharana KC, Singh S. Mitochondrial dysfunction in the pathogenesis of endothelial dysfunction. Mol Cell Biochem. 2024;479(8):1999\u20132016. https:\/\/doi.org\/10.1007\/s11010-023-04835-8.","journal-title":"Mol Cell Biochem"},{"issue":"7","key":"477_CR23","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.tim.2021.12.011","volume":"30","author":"J Foo","year":"2022","unstructured":"Foo J, Bellot G, Pervaiz S, Alonso S. Mitochondria-mediated oxidative stress during viral infection. Trends Microbiol. 2022;30(7):679\u201392. https:\/\/doi.org\/10.1016\/j.tim.2021.12.011.","journal-title":"Trends Microbiol"},{"issue":"1","key":"477_CR24","doi-asserted-by":"publisher","first-page":"H187","DOI":"10.1152\/ajpheart.00270.2023","volume":"325","author":"KO Murray","year":"2023","unstructured":"Murray KO, Ludwig KR, Darvish S, Coppock ME, Seals DR, Rossman MJ. Chronic mitochondria antioxidant treatment in older adults alters the circulating milieu to improve endothelial cell function and mitochondrial oxidative stress. Am J Physiol Heart Circ Physiol. 2023;325(1):H187\u201394. https:\/\/doi.org\/10.1152\/ajpheart.00270.2023.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5","key":"477_CR25","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1159\/000547281","volume":"62","author":"EM Kim","year":"2025","unstructured":"Kim EM, Han YH, Oh PS, Qi W, Lim ST, Jeong HJ. Mitochondria-targeted SS31-conjugated liposome attenuates oxidative stress in endothelial and skeletal muscle cells. J Vasc Res. 2025;62(5):274\u201388. https:\/\/doi.org\/10.1159\/000547281.","journal-title":"J Vasc Res"},{"key":"477_CR26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.mito.2023.01.007","volume":"69","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wu J, Wang J, He L, Lai H, Zhang T, et al. Mitochondrial oxidative stress in brain microvascular endothelial cells: triggering blood-brain barrier disruption. Mitochondrion. 2023;69:71\u201382. https:\/\/doi.org\/10.1016\/j.mito.2023.01.007.","journal-title":"Mitochondrion"},{"key":"477_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9070781","author":"P Theofilis","year":"2021","unstructured":"Theofilis P, Sagris M, Oikonomou E, Antonopoulos AS, Siasos G, Tsioufis C, et al. Inflammatory mechanisms contributing to endothelial dysfunction. Biomedicines. 2021. https:\/\/doi.org\/10.3390\/biomedicines9070781.","journal-title":"Biomedicines"},{"key":"477_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11101958","author":"Y Higashi","year":"2022","unstructured":"Higashi Y. Roles of oxidative stress and inflammation in vascular endothelial dysfunction-related disease. Antioxidants (Basel, Switzerland). 2022. https:\/\/doi.org\/10.3390\/antiox11101958.","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"477_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232415722","author":"G Pacinella","year":"2022","unstructured":"Pacinella G, Ciaccio AM, Tuttolomondo A. Endothelial dysfunction and chronic inflammation: the cornerstones of vascular alterations in age-related diseases. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms232415722.","journal-title":"Int J Mol Sci"},{"key":"477_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/cells12121640","author":"J Immanuel","year":"2023","unstructured":"Immanuel J, Yun S. Vascular inflammatory diseases and endothelial phenotypes. Cells. 2023. https:\/\/doi.org\/10.3390\/cells12121640.","journal-title":"Cells"},{"issue":"3","key":"477_CR31","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1055\/a-2601-9302","volume":"52","author":"M Marietta","year":"2026","unstructured":"Marietta M, Coluccio V, Cordella S, Luppi M. Impact of viral infections on the hemostatic system. Semin Thromb Hemost. 2026;52(3):315\u201326. https:\/\/doi.org\/10.1055\/a-2601-9302.","journal-title":"Semin Thromb Hemost"},{"key":"477_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/life13061420","author":"E Dri","year":"2023","unstructured":"Dri E, Lampas E, Lazaros G, Lazarou E, Theofilis P, Tsioufis C, et al. Inflammatory mediators of endothelial dysfunction. Life (Basel, Switzerland). 2023. https:\/\/doi.org\/10.3390\/life13061420.","journal-title":"Life (Basel, Switzerland)"},{"key":"477_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/cells11121935","author":"KEM Hellenthal","year":"2022","unstructured":"Hellenthal KEM, Brabenec L, Wagner NM. Regulation and dysregulation of endothelial permeability during systemic inflammation. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11121935.","journal-title":"Cells"},{"issue":"6","key":"477_CR34","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1007\/s11357-022-00616-1","volume":"44","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Yabluchanskiy A, Deng J, Amil FA, Po SS, Dasari TW. The role of age-associated autonomic dysfunction in inflammation and endothelial dysfunction. GeroScience. 2022;44(6):2655\u201370. https:\/\/doi.org\/10.1007\/s11357-022-00616-1.","journal-title":"GeroScience"},{"issue":"10","key":"477_CR35","doi-asserted-by":"publisher","first-page":"5413","DOI":"10.1096\/fj.201800173R","volume":"32","author":"G Liu","year":"2018","unstructured":"Liu G, Gong Y, Zhang R, Piao L, Li X, Liu Q, et al. Resolvin E1 attenuates injury-induced vascular neointimal formation by inhibition of inflammatory responses and vascular smooth muscle cell migration. FASEB J. 2018;32(10):5413\u201325. https:\/\/doi.org\/10.1096\/fj.201800173R.","journal-title":"FASEB J"},{"issue":"7","key":"477_CR36","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1089\/hum.2017.173","volume":"29","author":"Y He","year":"2018","unstructured":"He Y, Mei L, Jin Y, Li XP, Jin C. Overexpression of hepatocyte growth factor mRNA induced by gene transfer attenuates neointimal hyperplasia after balloon injury. Hum Gene Ther. 2018;29(7):816\u201327. https:\/\/doi.org\/10.1089\/hum.2017.173.","journal-title":"Hum Gene Ther"},{"issue":"3","key":"477_CR37","doi-asserted-by":"publisher","DOI":"10.1111\/apha.13037","volume":"223","author":"D Jian","year":"2018","unstructured":"Jian D, Wang W, Zhou X, Jia Z, Wang J, Yang M, et al. Interferon-induced protein 35 inhibits endothelial cell proliferation, migration and re-endothelialization of injured arteries by inhibiting the nuclear factor-kappa B pathway. Acta Physiol (Oxf). 2018;223(3):e13037. https:\/\/doi.org\/10.1111\/apha.13037.","journal-title":"Acta Physiol (Oxf)"},{"issue":"12 Pt B","key":"477_CR38","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1016\/j.bbalip.2015.12.013","volume":"1861","author":"D Santovito","year":"2016","unstructured":"Santovito D, Egea V, Weber C. Small but smart: microRNAs orchestrate atherosclerosis development and progression. Biochem Biophys Acta. 2016;1861(12 Pt B):2075\u201386. https:\/\/doi.org\/10.1016\/j.bbalip.2015.12.013.","journal-title":"Biochem Biophys Acta"},{"issue":"5","key":"477_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.a.37923","volume":"113","author":"L Li","year":"2025","unstructured":"Li L, An D, Zhao J, Yu Y, Zeng Y, Yang X, et al. Versatile coating via programmed assembly of miR-155 inhibitor and endothelial affinity peptide. J Biomed Mater Res A. 2025;113(5):e37923. https:\/\/doi.org\/10.1002\/jbm.a.37923.","journal-title":"J Biomed Mater Res A"},{"issue":"12","key":"477_CR40","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1161\/circresaha.120.317415","volume":"127","author":"R Aherrahrou","year":"2020","unstructured":"Aherrahrou R, Guo L, Nagraj VP, Aguhob A, Hinkle J, Chen L, et al. Genetic regulation of atherosclerosis-relevant phenotypes in human vascular smooth muscle cells. Circ Res. 2020;127(12):1552\u201365. https:\/\/doi.org\/10.1161\/circresaha.120.317415.","journal-title":"Circ Res"},{"issue":"1","key":"477_CR41","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-021-04079-z","volume":"79","author":"F Zhang","year":"2021","unstructured":"Zhang F, Guo X, Xia Y, Mao L. An update on the phenotypic switching of vascular smooth muscle cells in the pathogenesis of atherosclerosis. Cell Mol Life Sci. 2021;79(1):6. https:\/\/doi.org\/10.1007\/s00018-021-04079-z.","journal-title":"Cell Mol Life Sci"},{"key":"477_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/cells11244060","author":"HY Tang","year":"2022","unstructured":"Tang HY, Chen AQ, Zhang H, Gao XF, Kong XQ, Zhang JJ. Vascular smooth muscle cells phenotypic switching in cardiovascular diseases. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11244060.","journal-title":"Cells"},{"issue":"1","key":"477_CR43","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1161\/atvbaha.125.323131","volume":"46","author":"AB Herman","year":"2026","unstructured":"Herman AB, Gresova K, Maragkakis M, Autieri MV. Senescence: an overlooked VSMC phenotype and therapeutic opportunity? Arterioscler Thromb Vasc Biol. 2026;46(1):119\u201331. https:\/\/doi.org\/10.1161\/atvbaha.125.323131.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"477_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-022-00993-2","volume":"20","author":"G Cao","year":"2022","unstructured":"Cao G, Xuan X, Hu J, Zhang R, Jin H, Dong H. How vascular smooth muscle cell phenotype switching contributes to vascular disease. Cell Commun Signal. 2022;20(1):180. https:\/\/doi.org\/10.1186\/s12964-022-00993-2.","journal-title":"Cell Commun Signal"},{"issue":"5","key":"477_CR45","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/mnfr.201400791","volume":"59","author":"R Liu","year":"2015","unstructured":"Liu R, Heiss EH, Sider N, Schinkovitz A, Gr\u00f6blacher B, Guo D, et al. Identification and characterization of [6]-shogaol from ginger as inhibitor of vascular smooth muscle cell proliferation. Mol Nutr Food Res. 2015;59(5):843\u201352. https:\/\/doi.org\/10.1002\/mnfr.201400791.","journal-title":"Mol Nutr Food Res"},{"issue":"2","key":"477_CR46","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1089\/ars.2017.7171","volume":"29","author":"B Yu","year":"2018","unstructured":"Yu B, Chen Q, Le Bras A, Zhang L, Xu Q. Vascular stem\/progenitor cell migration and differentiation in atherosclerosis. Antioxid Redox Signal. 2018;29(2):219\u201335. https:\/\/doi.org\/10.1089\/ars.2017.7171.","journal-title":"Antioxid Redox Signal"},{"key":"477_CR47","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/7651_2021_378","volume":"2549","author":"BC Dash","year":"2022","unstructured":"Dash BC, Hsia HC. Generation and encapsulation of Human iPSC-derived vascular smooth muscle cells for proangiogenic therapy. Methods Mol Biol (Clifton, NJ). 2022;2549:259\u201369. https:\/\/doi.org\/10.1007\/7651_2021_378.","journal-title":"Methods Mol Biol (Clifton, NJ)"},{"issue":"12","key":"477_CR48","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1093\/cvr\/cvad110","volume":"119","author":"N Zhu","year":"2023","unstructured":"Zhu N, Guo ZF, Kazama K, Yi B, Tongmuang N, Yao H, et al. Epigenetic regulation of vascular smooth muscle cell phenotypic switch and neointimal formation by PRMT5. Cardiovasc Res. 2023;119(12):2244\u201355. https:\/\/doi.org\/10.1093\/cvr\/cvad110.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"477_CR49","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-023-05095-x","volume":"81","author":"C Su","year":"2024","unstructured":"Su C, Liu M, Yao X, Hao W, Ma J, Ren Y, et al. Vascular injury activates the ELK1\/SND1\/SRF pathway to promote vascular smooth muscle cell proliferative phenotype and neointimal hyperplasia. Cell Mol Life Sci. 2024;81(1):59. https:\/\/doi.org\/10.1007\/s00018-023-05095-x.","journal-title":"Cell Mol Life Sci"},{"issue":"9","key":"477_CR50","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1111\/bph.17436","volume":"182","author":"FR Zhang","year":"2025","unstructured":"Zhang FR, Tang J, Lai Y, Mo SQ, Lin ZM, Lei QQ, et al. Smooth muscle cell Piezo1 is essential for phenotypic switch and neointimal hyperplasia. Br J Pharmacol. 2025;182(9):2031\u201348. https:\/\/doi.org\/10.1111\/bph.17436.","journal-title":"Br J Pharmacol"},{"issue":"4","key":"477_CR51","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/path.6052","volume":"259","author":"K Cao","year":"2023","unstructured":"Cao K, Zhang T, Li Z, Song M, Li A, Yan J, et al. Glycolysis and de novo fatty acid synthesis cooperatively regulate pathological vascular smooth muscle cell phenotypic switching and neointimal hyperplasia. J Pathol. 2023;259(4):388\u2013401. https:\/\/doi.org\/10.1002\/path.6052.","journal-title":"J Pathol"},{"key":"477_CR52","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.atherosclerosis.2022.08.010","volume":"357","author":"JX Liu","year":"2022","unstructured":"Liu JX, Huang T, Xie D, Yu Q. Bves maintains vascular smooth muscle cell contractile phenotype and protects against transplant vasculopathy via Dusp1-dependent p38MAPK and ERK1\/2 signaling. Atherosclerosis. 2022;357:20\u201332. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2022.08.010.","journal-title":"Atherosclerosis"},{"key":"477_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054950","author":"F Pankratz","year":"2023","unstructured":"Pankratz F, Maksudova A, Goesele R, Meier L, Proelss K, Marenne K, et al. BMPER improves vascular remodeling and the contractile vascular SMC phenotype. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24054950.","journal-title":"Int J Mol Sci"},{"key":"477_CR54","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.190089","author":"Z Lin","year":"2025","unstructured":"Lin Z, Wang C, Wen Z, Cai Z, Guo W, Feng X, et al. NEXN regulates vascular smooth muscle cell phenotypic switching and neointimal hyperplasia. JCI insight. 2025. https:\/\/doi.org\/10.1172\/jci.insight.190089.","journal-title":"JCI insight"},{"issue":"14","key":"477_CR55","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1093\/cvr\/cvaf192","volume":"121","author":"Q Chen","year":"2025","unstructured":"Chen Q, Liu J, Madonna R, Li F, Chen S, Li L, et al. Vasostatin-2 attenuates injury-induced neointimal hyperplasia through the ACE2\/MasR\/PPAR\u03b3\/NR1D1\/Gas1 axis. Cardiovasc Res. 2025;121(14):2260\u201377. https:\/\/doi.org\/10.1093\/cvr\/cvaf192.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"477_CR56","doi-asserted-by":"publisher","first-page":"C183","DOI":"10.1152\/ajpcell.00074.2022","volume":"324","author":"HL Qin","year":"2023","unstructured":"Qin HL, Bao JH, Tang JJ, Xu DY, Shen L. Arterial remodeling: the role of mitochondrial metabolism in vascular smooth muscle cells. Am J Physiol Cell Physiol. 2023;324(1):C183\u201392. https:\/\/doi.org\/10.1152\/ajpcell.00074.2022.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"477_CR57","doi-asserted-by":"publisher","first-page":"C442","DOI":"10.1152\/ajpcell.00354.2023","volume":"326","author":"WJ Pearce","year":"2024","unstructured":"Pearce WJ. Mitochondrial influences on smooth muscle phenotype. Am J Physiol Cell Physiol. 2024;326(2):C442\u20138. https:\/\/doi.org\/10.1152\/ajpcell.00354.2023.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"477_CR58","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1093\/cvr\/cvv005","volume":"106","author":"L Wang","year":"2015","unstructured":"Wang L, Yu T, Lee H, O\u2019Brien DK, Sesaki H, Yoon Y. Decreasing mitochondrial fission diminishes vascular smooth muscle cell migration and ameliorates intimal hyperplasia. Cardiovasc Res. 2015;106(2):272\u201383. https:\/\/doi.org\/10.1093\/cvr\/cvv005.","journal-title":"Cardiovasc Res"},{"issue":"4","key":"477_CR59","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1161\/atvbaha.124.321730","volume":"45","author":"Y Liu","year":"2025","unstructured":"Liu Y, Yu M, Wang H, Dorsey KH, Cheng Y, Zhao Y, et al. Restoring Vascular Smooth Muscle Cell Mitochondrial Function Attenuates Abdominal Aortic Aneurysm in Mice. Arterioscler Thromb Vasc Biol. 2025;45(4):523\u201340. https:\/\/doi.org\/10.1161\/atvbaha.124.321730.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"477_CR60","doi-asserted-by":"publisher","first-page":"H1112","DOI":"10.1152\/ajpheart.00089.2018","volume":"315","author":"SJ Parker","year":"2018","unstructured":"Parker SJ, Stotland A, MacFarlane E, Wilson N, Orosco A, Venkatraman V, et al. Proteomics reveals Rictor as a noncanonical TGF-\u03b2 signaling target during aneurysm progression in Marfan mice. Am J Physiol Heart Circ Physiol. 2018;315(5):H1112\u201326. https:\/\/doi.org\/10.1152\/ajpheart.00089.2018.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"477_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116858","volume":"176","author":"J Sun","year":"2024","unstructured":"Sun J, Shao Y, Pei L, Zhu Q, Yu X, Yao W. AKAP1 alleviates VSMC phenotypic modulation and neointima formation by inhibiting Drp1-dependent mitochondrial fission. Biomed Pharmacother. 2024;176:116858. https:\/\/doi.org\/10.1016\/j.biopha.2024.116858.","journal-title":"Biomed Pharmacother"},{"key":"477_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102778","volume":"64","author":"J Li","year":"2023","unstructured":"Li J, Li X, Song S, Sun Z, Li Y, Yang L, et al. Mitochondria spatially and temporally modulate VSMC phenotypes via interacting with cytoskeleton in cardiovascular diseases. Redox Biol. 2023;64:102778. https:\/\/doi.org\/10.1016\/j.redox.2023.102778.","journal-title":"Redox Biol"},{"key":"477_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043483","author":"Y Xia","year":"2023","unstructured":"Xia Y, Zhang X, An P, Luo J, Luo Y. Mitochondrial homeostasis in VSMCs as a central hub in vascular remodeling. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24043483.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"477_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-21905-7","volume":"15","author":"C Wu","year":"2025","unstructured":"Wu C, Wu Z, Hu L, Tang L, Hu X, Fang C. SIRT1\/PGC-1\u03b1\/Mfn2 pathway regulates mitochondrial homeostasis in VSMC to attenuate aging-related vascular calcification. Sci Rep. 2025;15(1):38045. https:\/\/doi.org\/10.1038\/s41598-025-21905-7.","journal-title":"Sci Rep"},{"issue":"6","key":"477_CR65","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s00018-023-04793-w","volume":"80","author":"G Wang","year":"2023","unstructured":"Wang G, Luo Y, Gao X, Liang Y, Yang F, Wu J, et al. MicroRNA regulation of phenotypic transformations in vascular smooth muscle: relevance to vascular remodeling. Cell Mol Life Sci CMLS. 2023;80(6):144. https:\/\/doi.org\/10.1007\/s00018-023-04793-w.","journal-title":"Cell Mol Life Sci CMLS"},{"issue":"6","key":"477_CR66","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.cellsig.2014.12.022","volume":"27","author":"N Choe","year":"2015","unstructured":"Choe N, Kwon JS, Kim YS, Eom GH, Ahn YK, Baik YH, et al. The microRNA miR-34c inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia by targeting stem cell factor. Cell Signal. 2015;27(6):1056\u201365. https:\/\/doi.org\/10.1016\/j.cellsig.2014.12.022.","journal-title":"Cell Signal"},{"issue":"11","key":"477_CR67","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.2174\/0113862073295224240529141030","volume":"28","author":"Z Wu","year":"2025","unstructured":"Wu Z, Lin J, Yan L, Yang W. MiR-140-3p normalizes vascular smooth muscle cell behavior by inhibiting the RhoA\/ROCK signaling pathway in lower-extremity arteriosclerosis obliterans. Comb Chem High Throughput Screen. 2025;28(11):1901\u201310. https:\/\/doi.org\/10.2174\/0113862073295224240529141030.","journal-title":"Comb Chem High Throughput Screen"},{"key":"477_CR68","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.avsg.2025.05.039","volume":"122","author":"M Zhang","year":"2026","unstructured":"Zhang M, Wang C, Liu J, Zhang J, Zhuang B, Jia X, et al. Two-year outcomes of drug-coated balloons versus standard balloons for femoropopliteal artery in-stent restenosis: evidence from the AcoArt I trial. Ann Vasc Surg. 2026;122:43\u201352. https:\/\/doi.org\/10.1016\/j.avsg.2025.05.039.","journal-title":"Ann Vasc Surg"},{"issue":"1","key":"477_CR69","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1177\/0885328216630498","volume":"31","author":"SY Lee","year":"2016","unstructured":"Lee SY, Bae IH, Sung Park D, Jang EJ, Shim JW, Lim KS, et al. Prednisolone- and sirolimus-eluting stent: anti-inflammatory approach for inhibiting in-stent restenosis. J Biomater Appl. 2016;31(1):36\u201344. https:\/\/doi.org\/10.1177\/0885328216630498.","journal-title":"J Biomater Appl"},{"key":"477_CR70","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.6007.1","volume":"4","author":"R Liu","year":"2015","unstructured":"Liu R, Heiss EH, Guo D, Dirsch VM, Atanasov AG. Capsaicin from chili (Capsicum spp.) inhibits vascular smooth muscle cell proliferation. F1000Res. 2015;4:26. https:\/\/doi.org\/10.12688\/f1000research.6007.1.","journal-title":"F1000Res"},{"issue":"1","key":"477_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s13020-024-01051-4","volume":"20","author":"JM Kim","year":"2025","unstructured":"Kim JM, Kim Y, Na HJ, Hur HJ, Lee SH, Sung MJ. Magnolia kobus DC. suppresses neointimal hyperplasia by regulating ferroptosis and VSMC phenotypic switching in a carotid artery ligation mouse model. Chin Med. 2025;20(1):3. https:\/\/doi.org\/10.1186\/s13020-024-01051-4.","journal-title":"Chin Med"},{"key":"477_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/cells14231922","author":"Y Shao","year":"2025","unstructured":"Shao Y, Yi L, Zhu Q, Zhou Y, Chen T, Yao W. Ginkgolic acid inhibits VSMC proliferation and migration and vascular restenosis by regulating cell cycle progression and cytoskeleton rearrangement through TCTN1. Cells. 2025. https:\/\/doi.org\/10.3390\/cells14231922.","journal-title":"Cells"},{"issue":"6","key":"477_CR73","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1161\/atvbaha.124.322252","volume":"45","author":"H Jiang","year":"2025","unstructured":"Jiang H, Zhao Y, Jin M, Zhang Z, Wang L, Cheng X, et al. Colchicine inhibits smooth muscle cell phenotypic switch and aortic dissection in mice-brief report. Arterioscler Thromb Vasc Biol. 2025;45(6):979\u201384. https:\/\/doi.org\/10.1161\/atvbaha.124.322252.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"17","key":"477_CR74","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1161\/01.Cir.0000069943.41206.Bd","volume":"107","author":"PK Shah","year":"2003","unstructured":"Shah PK. Inflammation, neointimal hyperplasia, and restenosis: as the leukocytes roll, the arteries thicken. Circulation. 2003;107(17):2175\u20137. https:\/\/doi.org\/10.1161\/01.Cir.0000069943.41206.Bd.","journal-title":"Circulation"},{"issue":"1","key":"477_CR75","doi-asserted-by":"publisher","DOI":"10.1080\/10641963.2023.2229538","volume":"45","author":"X Xu","year":"2023","unstructured":"Xu X, Xie L, Chai L, Wang X, Dong J, Wang J, et al. Ketogenic diet inhibits neointimal hyperplasia by suppressing oxidative stress and inflammation. Clin Exp Hypertension (New York, NY\u202f: 1993). 2023;45(1):2229538. https:\/\/doi.org\/10.1080\/10641963.2023.2229538.","journal-title":"Clin Exp Hypertension (New York, NY : 1993)"},{"key":"477_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2024.107419","volume":"156","author":"CDA Mackay","year":"2024","unstructured":"Mackay CDA, Meechem MB, Patel VB. Macrophages in vascular disease: roles of mitochondria and metabolic mechanisms. Vasc Pharmacol. 2024;156:107419. https:\/\/doi.org\/10.1016\/j.vph.2024.107419.","journal-title":"Vasc Pharmacol"},{"issue":"6","key":"477_CR77","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1210\/en.2014-1841","volume":"156","author":"J Luo","year":"2015","unstructured":"Luo J, Liang M, Mitch WE, Danesh FR, Yu M, Cheng J. FSP-1 impairs the function of endothelium leading to failure of arteriovenous grafts in diabetic mice. Endocrinology. 2015;156(6):2200\u201310. https:\/\/doi.org\/10.1210\/en.2014-1841.","journal-title":"Endocrinology"},{"issue":"7","key":"477_CR78","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1161\/circresaha.116.305987","volume":"116","author":"LJ Chen","year":"2015","unstructured":"Chen LJ, Chuang L, Huang YH, Zhou J, Lim SH, Lee CI, et al. MicroRNA mediation of endothelial inflammatory response to smooth muscle cells and its inhibition by atheroprotective shear stress. Circ Res. 2015;116(7):1157\u201369. https:\/\/doi.org\/10.1161\/circresaha.116.305987.","journal-title":"Circ Res"},{"key":"477_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110412","volume":"121","author":"L He","year":"2023","unstructured":"He L, Liu D, Zhou W, Han Y, Ju Y, Liu H, et al. The innate immune sensor STING accelerates neointima formation via NF-\u03baB signaling pathway. Int Immunopharmacol. 2023;121:110412. https:\/\/doi.org\/10.1016\/j.intimp.2023.110412.","journal-title":"Int Immunopharmacol"},{"key":"477_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252111473","author":"C Baeza","year":"2024","unstructured":"Baeza C, Ribagorda M, Maya-Lopez C, Fresno M, Sanchez-Diaz T, Pintor-Chocano A, et al. NIK is a mediator of inflammation and intimal hyperplasia in endothelial denudation-induced vascular injury. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms252111473.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"477_CR81","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1007\/s11033-025-11050-9","volume":"52","author":"A Anwar","year":"2025","unstructured":"Anwar A, Khan MJ. Pathogenic and clinical significance of inflammation-associated microRNAs in cardiovascular diseases. Mol Biol Rep. 2025;52(1):940\u2013940. https:\/\/doi.org\/10.1007\/s11033-025-11050-9.","journal-title":"Mol Biol Rep"},{"key":"477_CR82","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231912012","author":"V Rai","year":"2022","unstructured":"Rai V, Singh H, Agrawal DK. Targeting the crosstalk of immune response and vascular smooth muscle cells phenotype switch for arteriovenous fistula maturation. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms231912012.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"477_CR83","doi-asserted-by":"publisher","first-page":"191","DOI":"10.12793\/tcp.2023.31.e18","volume":"31","author":"R Dinc","year":"2023","unstructured":"Dinc R. A review of the current state in neointimal hyperplasia development following endovascular intervention and minor emphasis on new horizons in immunotherapy. Transl Clin Pharmacol. 2023;31(4):191\u2013201. https:\/\/doi.org\/10.12793\/tcp.2023.31.e18.","journal-title":"Transl Clin Pharmacol"},{"key":"477_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrep.2023.101567","volume":"36","author":"H Wei","year":"2023","unstructured":"Wei H, Liu R, Zhao M, Ma Y, He Y, Sun X. Ischemia\u2012Reperfusion accelerates neointimal hyperplasia via IL-1\u03b2-mediated pyroptosis after balloon injury in the rat carotid artery. Biochem Biophys Rep. 2023;36:101567. https:\/\/doi.org\/10.1016\/j.bbrep.2023.101567.","journal-title":"Biochem Biophys Rep"},{"key":"477_CR85","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16071435","author":"CS Boosani","year":"2024","unstructured":"Boosani CS, Burela L. The exacerbating effects of the tumor necrosis factor in cardiovascular stenosis: intimal hyperplasia. Cancers Basel. 2024. https:\/\/doi.org\/10.3390\/cancers16071435.","journal-title":"Cancers Basel"},{"issue":"3","key":"477_CR86","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1161\/circresaha.122.321837","volume":"132","author":"G Zhang","year":"2023","unstructured":"Zhang G, Qin Q, Zhang C, Sun X, Kazama K, Yi B, et al. NDRG1 signaling is essential for endothelial inflammation and vascular remodeling. Circ Res. 2023;132(3):306\u201319. https:\/\/doi.org\/10.1161\/circresaha.122.321837.","journal-title":"Circ Res"},{"issue":"19","key":"477_CR87","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202408992","volume":"12","author":"J Miao","year":"2025","unstructured":"Miao J, Yong Y, Zheng Z, Zhang K, Li W, Liu J, et al. Artesunate inhibits neointimal hyperplasia by promoting IRF4 associated macrophage polarization. Adv Sci (Weinheim, Baden-Wurttemberg, Germany). 2025;12(19):e2408992. https:\/\/doi.org\/10.1002\/advs.202408992.","journal-title":"Adv Sci (Weinheim, Baden-Wurttemberg, Germany)"},{"issue":"8","key":"477_CR88","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1111\/bph.14041","volume":"175","author":"G Liu","year":"2018","unstructured":"Liu G, Liu Q, Shen Y, Kong D, Gong Y, Tao B, et al. Early treatment with Resolvin E1 facilitates myocardial recovery from ischaemia in mice. Br J Pharmacol. 2018;175(8):1205\u201316. https:\/\/doi.org\/10.1111\/bph.14041.","journal-title":"Br J Pharmacol"},{"issue":"2","key":"477_CR89","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0264217","volume":"17","author":"AS Kim","year":"2022","unstructured":"Kim AS, Werlin EC, Kagaya H, Chen M, Wu B, Mottola G, et al. 17R\/S-Benzo-RvD1, a synthetic resolvin D1 analogue, attenuates neointimal hyperplasia in a rat model of acute vascular injury. PLoS ONE. 2022;17(2):e0264217. https:\/\/doi.org\/10.1371\/journal.pone.0264217.","journal-title":"PLoS ONE"},{"issue":"9","key":"477_CR90","first-page":"6123","volume":"14","author":"M Zhang","year":"2022","unstructured":"Zhang M, Zhang M, Wang W, Chen H, Wang X, Zhao K, et al. Dehydroepiandrosterone inhibits vascular proliferation and inflammation by modulating the miR-486a-3p\/NLRP3 axis. Am J Transl Res. 2022;14(9):6123\u201336.","journal-title":"Am J Transl Res"},{"key":"477_CR91","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25094814","author":"C Baeza","year":"2024","unstructured":"Baeza C, Pintor-Chocano A, Carrasco S, Sanz A, Ortiz A, Sanchez-Ni\u00f1o MD. Paricalcitol has a potent anti-inflammatory effect in rat endothelial denudation-induced intimal hyperplasia. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25094814.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"477_CR92","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/cvr\/cvp238","volume":"84","author":"G Grassia","year":"2009","unstructured":"Grassia G, Maddaluno M, Guglielmotti A, Mangano G, Biondi G, Maffia P, et al. The anti-inflammatory agent bindarit inhibits neointima formation in both rats and hyperlipidaemic mice. Cardiovasc Res. 2009;84(3):485\u201393. https:\/\/doi.org\/10.1093\/cvr\/cvp238.","journal-title":"Cardiovasc Res"},{"issue":"4","key":"477_CR93","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s12975-018-0660-9","volume":"10","author":"SL Lin","year":"2019","unstructured":"Lin SL, Yeh JL, Tsai PC, Chang TH, Huang WC, Lee ST, et al. Inhibition of Neointima Hyperplasia, Inflammation, and Reactive Oxygen Species in Balloon-Injured Arteries by HVJ Envelope Vector-Mediated Delivery of Superoxide Dismutase Gene. Transl Stroke Res. 2019;10(4):413\u201327. https:\/\/doi.org\/10.1007\/s12975-018-0660-9.","journal-title":"Transl Stroke Res"},{"key":"477_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17217825","author":"R Che Man","year":"2020","unstructured":"Che Man R, Sulaiman N, Ishak MF, Bt Hj Idrus R, Abdul Rahman MR, Yazid MD. The effects of pro-inflammatory and anti-inflammatory agents for the suppression of intimal hyperplasia: an evidence-based review. Int J Environ Res Public Health. 2020. https:\/\/doi.org\/10.3390\/ijerph17217825.","journal-title":"Int J Environ Res Public Health"},{"issue":"6","key":"477_CR95","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3109\/08923973.2014.956754","volume":"36","author":"ZW Zhao","year":"2014","unstructured":"Zhao ZW, Abendroth DK, Zhou ZC, Liu YZ, Pan FM, Ge JJ. Anti-inflammatory and anti-proliferative effects of CBS3830 in arterialized vein grafts in rats. Immunopharmacol Immunotoxicol. 2014;36(6):397\u2013403. https:\/\/doi.org\/10.3109\/08923973.2014.956754.","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"4","key":"477_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0052-y","volume":"50","author":"JH Park","year":"2018","unstructured":"Park JH, Kim SW, Cha MJ, Yoon N, Lee CY, Lee J, et al. TAK-733 inhibits inflammatory neointimal formation by suppressing proliferation, migration, and inflammation in vitro and in vivo. Exp Mol Med. 2018;50(4):1\u201312. https:\/\/doi.org\/10.1038\/s12276-018-0052-y.","journal-title":"Exp Mol Med"},{"issue":"4","key":"477_CR97","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1002\/jbm.b.33955","volume":"106","author":"IH Bae","year":"2018","unstructured":"Bae IH, Park DS, Lee SY, Jang EJ, Shim JW, Lim KS, et al. Bilirubin coating attenuates the inflammatory response to everolimus-coated stents. J Biomed Mater Res B Appl Biomater. 2018;106(4):1486\u201395. https:\/\/doi.org\/10.1002\/jbm.b.33955.","journal-title":"J Biomed Mater Res B Appl Biomater"},{"issue":"291","key":"477_CR98","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaa4549","volume":"7","author":"BC Evans","year":"2015","unstructured":"Evans BC, Hocking KM, Osgood MJ, Voskresensky I, Dmowska J, Kilchrist KV, et al. MK2 inhibitory peptide delivered in nanopolyplexes prevents vascular graft intimal hyperplasia. Sci Transl Med. 2015;7(291):291ra95. https:\/\/doi.org\/10.1126\/scitranslmed.aaa4549.","journal-title":"Sci Transl Med"},{"key":"477_CR99","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.actbio.2024.02.022","volume":"179","author":"L Wen","year":"2024","unstructured":"Wen L, Qiu H, Li S, Huang Y, Tu Q, Lyu N, et al. Vascular stent with immobilized anti-inflammatory chemerin 15 peptides mitigates neointimal hyperplasia and accelerates vascular healing. Acta Biomater. 2024;179:371\u201384. https:\/\/doi.org\/10.1016\/j.actbio.2024.02.022.","journal-title":"Acta Biomater"},{"issue":"1","key":"477_CR100","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/circresaha.115.304457","volume":"116","author":"Z Lin","year":"2015","unstructured":"Lin Z, Zhou P, von Gise A, Gu F, Ma Q, Chen J, et al. Pi3kcb links Hippo-YAP and PI3K-AKT signaling pathways to promote cardiomyocyte proliferation and survival. Circ Res. 2015;116(1):35\u201345. https:\/\/doi.org\/10.1161\/circresaha.115.304457.","journal-title":"Circ Res"},{"issue":"7","key":"477_CR101","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1161\/01.Res.0000183730.52908.C6","volume":"97","author":"M Jonas","year":"2005","unstructured":"Jonas M, Edelman ER, Groothuis A, Baker AB, Seifert P, Rogers C. Vascular neointimal formation and signaling pathway activation in response to stent injury in insulin-resistant and diabetic animals. Circ Res. 2005;97(7):725\u201333. https:\/\/doi.org\/10.1161\/01.Res.0000183730.52908.C6.","journal-title":"Circ Res"},{"issue":"6","key":"477_CR102","doi-asserted-by":"publisher","first-page":"5472","DOI":"10.3892\/mmr.2020.11628","volume":"22","author":"J Cai","year":"2020","unstructured":"Cai J, Wang H, Sang H, Ye R, Cao Y, Jing M, et al. Insulin enhances neointimal hyperplasia following arterial injury through the PI3K\/Akt pathway in type 1 diabetic rats. Mol Med Rep. 2020;22(6):5472\u20138. https:\/\/doi.org\/10.3892\/mmr.2020.11628.","journal-title":"Mol Med Rep"},{"issue":"2","key":"477_CR103","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1024\/0301-1526\/a000080","volume":"40","author":"BC Zhang","year":"2011","unstructured":"Zhang BC, Zhou ZW, Li XK, Xu YW. PI-3K\/AKT signal pathway modulates vascular smooth muscle cells migration under cyclic mechanical strain. VASA. 2011;40(2):109\u201316. https:\/\/doi.org\/10.1024\/0301-1526\/a000080.","journal-title":"VASA"},{"issue":"13","key":"477_CR104","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1161\/circulationaha.109.848911","volume":"120","author":"S Bonnet","year":"2009","unstructured":"Bonnet S, Paulin R, Sutendra G, Dromparis P, Roy M, Watson KO, et al. Dehydroepiandrosterone reverses systemic vascular remodeling through the inhibition of the Akt\/GSK3-{beta}\/NFAT axis. Circulation. 2009;120(13):1231\u201340. https:\/\/doi.org\/10.1161\/circulationaha.109.848911.","journal-title":"Circulation"},{"issue":"11","key":"477_CR105","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1161\/01.Res.0000105086.31909.1b","volume":"93","author":"E Stabile","year":"2003","unstructured":"Stabile E, Zhou YF, Saji M, Castagna M, Shou M, Kinnaird TD, et al. Akt controls vascular smooth muscle cell proliferation in vitro and in vivo by delaying G1\/S exit. Circ Res. 2003;93(11):1059\u201365. https:\/\/doi.org\/10.1161\/01.Res.0000105086.31909.1b.","journal-title":"Circ Res"},{"issue":"48","key":"477_CR106","doi-asserted-by":"publisher","first-page":"19006","DOI":"10.1073\/pnas.0809743105","volume":"105","author":"J Shan","year":"2008","unstructured":"Shan J, Nguyen TB, Totary-Jain H, Dansky H, Marx SO, Marks AR. Leptin-enhanced neointimal hyperplasia is reduced by mTOR and PI3K inhibitors. Proc Natl Acad Sci U S A. 2008;105(48):19006\u201311. https:\/\/doi.org\/10.1073\/pnas.0809743105.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"477_CR107","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s11883-025-01364-1","volume":"27","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Han L, Wang Y, Wang M. The role of the PI3K\/Akt\/mTOR pathway in atherosclerosis: mechanisms, therapeutic potential, and emerging targeted treatments. Curr Atheroscler Rep. 2025;27(1):115. https:\/\/doi.org\/10.1007\/s11883-025-01364-1.","journal-title":"Curr Atheroscler Rep"},{"issue":"1","key":"477_CR108","doi-asserted-by":"publisher","DOI":"10.1186\/s13019-024-03253-1","volume":"20","author":"J Zhang","year":"2025","unstructured":"Zhang J, Zhu J, Sui B, Wang Y, Zhang B. Effect of rapamycin-eluting stents on in-stent restenosis and early inflammatory response in coronary artery narrowing animal models. J Cardiothorac Surg. 2025;20(1):84. https:\/\/doi.org\/10.1186\/s13019-024-03253-1.","journal-title":"J Cardiothorac Surg"},{"issue":"6","key":"477_CR109","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.7150\/thno.104650","volume":"15","author":"X Xu","year":"2025","unstructured":"Xu X, Zhu P, Wang H, Chen K, Liu L, Du L, et al. CD34(+) PI16(+) fibroblast progenitors aggravate neointimal lesions of allograft arteries via CCL11\/CCR3-PI3K\/AKT pathway. Theranostics. 2025;15(6):2523\u201343. https:\/\/doi.org\/10.7150\/thno.104650.","journal-title":"Theranostics"},{"issue":"11","key":"477_CR110","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1161\/01.Atv.0000095161.06906.Ed","volume":"23","author":"RH Zhou","year":"2003","unstructured":"Zhou RH, Lee TS, Tsou TC, Rannou F, Li YS, Chien S, et al. Stent implantation activates Akt in the vessel wall: role of mechanical stretch in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2003;23(11):2015\u201320. https:\/\/doi.org\/10.1161\/01.Atv.0000095161.06906.Ed.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"477_CR111","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1080\/13880209.2020.1845748","volume":"58","author":"HK Lu","year":"2020","unstructured":"Lu HK, Huang Y, Liang XY, Dai YY, Liu XT. Pinellia ternata attenuates carotid artery intimal hyperplasia and increases endothelial progenitor cell activity via the PI3K\/Akt signalling pathway in wire-injured rats. Pharm Biol. 2020;58(1):1184\u201391. https:\/\/doi.org\/10.1080\/13880209.2020.1845748.","journal-title":"Pharm Biol"},{"issue":"2","key":"477_CR112","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1161\/01.str.31.2.498","volume":"31","author":"AC Desfaits","year":"2000","unstructured":"Desfaits AC, Raymond J, Muizelaar JP. Growth factors stimulate neointimal cells in vitro and increase the thickness of the neointima formed at the neck of porcine aneurysms treated by embolization. Stroke. 2000;31(2):498\u2013507. https:\/\/doi.org\/10.1161\/01.str.31.2.498.","journal-title":"Stroke"},{"issue":"1","key":"477_CR113","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/jcb.22924","volume":"112","author":"L Li","year":"2011","unstructured":"Li L, Blumenthal DK, Terry CM, He Y, Carlson ML, Cheung AK. PDGF-induced proliferation in human arterial and venous smooth muscle cells: molecular basis for differential effects of PDGF isoforms. J Cell Biochem. 2011;112(1):289\u201398. https:\/\/doi.org\/10.1002\/jcb.22924.","journal-title":"J Cell Biochem"},{"issue":"6","key":"477_CR114","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1159\/000369461","volume":"51","author":"M Nurminskaya","year":"2014","unstructured":"Nurminskaya M, Beazley KE, Smith EP, Belkin AM. Transglutaminase 2 promotes PDGF-mediated activation of PDGFR\/Akt1 and \u03b2-catenin signaling in vascular smooth muscle cells and supports neointima formation. J Vasc Res. 2014;51(6):418\u201328. https:\/\/doi.org\/10.1159\/000369461.","journal-title":"J Vasc Res"},{"issue":"1-2","key":"477_CR115","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s11010-011-1076-y","volume":"360","author":"HZ Yu","year":"2012","unstructured":"Yu HZ, Xie LD, Zhu PL, Xu CS, Wang HJ. Human tissue kallikrein 1 gene delivery inhibits PDGF-BB-induced vascular smooth muscle cells proliferation and upregulates the expressions of p27Kip1 and p2lCip1. Mol Cell Biochem. 2012;360(1\u20132):363\u201371. https:\/\/doi.org\/10.1007\/s11010-011-1076-y.","journal-title":"Mol Cell Biochem"},{"key":"477_CR116","doi-asserted-by":"publisher","DOI":"10.3390\/cells10123327","author":"Z Wang","year":"2021","unstructured":"Wang Z. Regulation of cell cycle progression by growth factor-induced cell signaling. Cells Basel. 2021. https:\/\/doi.org\/10.3390\/cells10123327.","journal-title":"Cells Basel"},{"issue":"1","key":"477_CR117","doi-asserted-by":"publisher","first-page":"C191","DOI":"10.1152\/ajpcell.00417.2008","volume":"298","author":"GM Risinger Jr.","year":"2010","unstructured":"Risinger GM Jr., Updike DL, Bullen EC, Tomasek JJ, Howard EW. TGF-beta suppresses the upregulation of MMP-2 by vascular smooth muscle cells in response to PDGF-BB. Am J Physiol Cell Physiol. 2010;298(1):C191-201. https:\/\/doi.org\/10.1152\/ajpcell.00417.2008.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"4","key":"477_CR118","doi-asserted-by":"publisher","first-page":"L698","DOI":"10.1152\/ajplung.00529.2007","volume":"294","author":"MC Simeone-Penney","year":"2008","unstructured":"Simeone-Penney MC, Severgnini M, Rozo L, Takahashi S, Cochran BH, Simon AR. PDGF-induced human airway smooth muscle cell proliferation requires STAT3 and the small GTPase Rac1. Am J Physiol Lung Cell Mol Physiol. 2008;294(4):L698-704. https:\/\/doi.org\/10.1152\/ajplung.00529.2007.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"477_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrep.2024.101828","volume":"40","author":"E W\u00e5hl\u00e9n","year":"2024","unstructured":"W\u00e5hl\u00e9n E, Lennartsson J, Heldin J. Depletion of the Rho GTPases Cdc42, Rac1 or RhoA reduces PDGF-induced STAT1 and STAT3 signaling. Biochem Biophys Rep. 2024;40:101828. https:\/\/doi.org\/10.1016\/j.bbrep.2024.101828.","journal-title":"Biochem Biophys Rep"},{"issue":"5","key":"477_CR120","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1111\/j.1476-5381.2012.01866.x","volume":"166","author":"A Fougerat","year":"2012","unstructured":"Fougerat A, Smirnova NF, Gayral S, Malet N, Hirsch E, Wymann MP, et al. Key role of PI3K\u03b3 in monocyte chemotactic protein-1-mediated amplification of PDGF-induced aortic smooth muscle cell migration. Br J Pharmacol. 2012;166(5):1643\u201353. https:\/\/doi.org\/10.1111\/j.1476-5381.2012.01866.x.","journal-title":"Br J Pharmacol"},{"issue":"7","key":"477_CR121","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1152\/physiolgenomics.00160.2011","volume":"44","author":"MR Alexander","year":"2012","unstructured":"Alexander MR, Murgai M, Moehle CW, Owens GK. Interleukin-1\u03b2 modulates smooth muscle cell phenotype to a distinct inflammatory state relative to PDGF-DD via NF-\u03baB-dependent mechanisms. Physiol Genomics. 2012;44(7):417\u201329. https:\/\/doi.org\/10.1152\/physiolgenomics.00160.2011.","journal-title":"Physiol Genomics"},{"issue":"1","key":"477_CR122","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-022-03140-2","volume":"5","author":"S Hildebrand","year":"2022","unstructured":"Hildebrand S, Ibrahim M, Schlitzer A, Maegdefessel L, R\u00f6ll W, Pfeifer A. PDGF regulates guanylate cyclase expression and cGMP signaling in vascular smooth muscle. Commun Biol. 2022;5(1):197. https:\/\/doi.org\/10.1038\/s42003-022-03140-2.","journal-title":"Commun Biol"},{"issue":"1","key":"477_CR123","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3892\/mmr.2016.5986","volume":"15","author":"C Huang","year":"2017","unstructured":"Huang C, Mei H, Zhou M, Zheng X. A novel PDGF receptor inhibitor-eluting stent attenuates in-stent neointima formation in a rabbit carotid model. Mol Med Rep. 2017;15(1):21\u20138. https:\/\/doi.org\/10.3892\/mmr.2016.5986.","journal-title":"Mol Med Rep"},{"key":"477_CR124","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173666","volume":"890","author":"P Pichavaram","year":"2021","unstructured":"Pichavaram P, Shawky NM, Hartney TJ, Jun JY, Segar L. Imatinib improves insulin resistance and inhibits injury-induced neointimal hyperplasia in high fat diet-fed mice. Eur J Pharmacol. 2021;890:173666. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173666.","journal-title":"Eur J Pharmacol"},{"key":"477_CR125","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26062667","author":"X Wang","year":"2025","unstructured":"Wang X, Liu R, Liu D. The role of the MAPK signaling pathway in cardiovascular disease: pathophysiological mechanisms and clinical therapy. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26062667.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"477_CR126","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1161\/01.hyp.36.3.330","volume":"36","author":"PL Tharaux","year":"2000","unstructured":"Tharaux PL, Chatziantoniou C, Fakhouri F, Dussaule JC. Angiotensin II activates collagen I gene through a mechanism involving the MAP\/ER kinase pathway. Hypertension (Dallas, Tex\u202f: 1979). 2000;36(3):330\u20136. https:\/\/doi.org\/10.1161\/01.hyp.36.3.330.","journal-title":"Hypertension (Dallas, Tex : 1979)"},{"issue":"11","key":"477_CR127","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1161\/hh1101.091267","volume":"88","author":"Y Izumi","year":"2001","unstructured":"Izumi Y, Kim S, Namba M, Yasumoto H, Miyazaki H, Hoshiga M, et al. Gene transfer of dominant-negative mutants of extracellular signal-regulated kinase and c-Jun NH2-terminal kinase prevents neointimal formation in balloon-injured rat artery. Circ Res. 2001;88(11):1120\u20136. https:\/\/doi.org\/10.1161\/hh1101.091267.","journal-title":"Circ Res"},{"issue":"9","key":"477_CR128","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1021\/np3002145","volume":"75","author":"YC Chien","year":"2012","unstructured":"Chien YC, Huang GJ, Cheng HC, Wu CH, Sheu MJ. Hispolon attenuates balloon-injured neointimal formation and modulates vascular smooth muscle cell migration via AKT and ERK phosphorylation. J Nat Prod. 2012;75(9):1524\u201333. https:\/\/doi.org\/10.1021\/np3002145.","journal-title":"J Nat Prod"},{"key":"477_CR129","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2121-10-52","volume":"10","author":"QW Chen","year":"2009","unstructured":"Chen QW, Edvinsson L, Xu CB. Role of ERK\/MAPK in endothelin receptor signaling in human aortic smooth muscle cells. BMC Cell Biol. 2009;10:52. https:\/\/doi.org\/10.1186\/1471-2121-10-52.","journal-title":"BMC Cell Biol"},{"issue":"1","key":"477_CR130","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/00015385.2017.1321908","volume":"73","author":"MH Kim","year":"2018","unstructured":"Kim MH, Kim CE, Kim SW. Rosuvastatin inhibits high glucose-stimulated upregulation of VCAM-1 via the MAPK-signalling pathway in endothelial cells. Acta Cardiol. 2018;73(1):13\u20138. https:\/\/doi.org\/10.1080\/00015385.2017.1321908.","journal-title":"Acta Cardiol"},{"key":"477_CR131","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-016-0023-z","volume":"21","author":"E Jin","year":"2016","unstructured":"Jin E, Han S, Son M, Kim SW. Cordyceps bassiana inhibits smooth muscle cell proliferation via the ERK1\/2 MAPK signaling pathway. Cell Mol Biol Lett. 2016;21:24. https:\/\/doi.org\/10.1186\/s11658-016-0023-z.","journal-title":"Cell Mol Biol Lett"},{"issue":"5","key":"477_CR132","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.229","volume":"5","author":"D Liu","year":"2014","unstructured":"Liu D, Huang Y, Bu D, Liu AD, Holmberg L, Jia Y, et al. Sulfur dioxide inhibits vascular smooth muscle cell proliferation via suppressing the Erk\/MAP kinase pathway mediated by cAMP\/PKA signaling. Cell Death Dis. 2014;5(5):e1251. https:\/\/doi.org\/10.1038\/cddis.2014.229.","journal-title":"Cell Death Dis"},{"issue":"1-2","key":"477_CR133","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s11010-020-03878-5","volume":"475","author":"E Liu","year":"2020","unstructured":"Liu E, Shi S, Li J, Ge R, Liang T, Li Q. Farrerol maintains the contractile phenotype of VSMCs via inactivating the extracellular signal-regulated protein kinase 1\/2 and p38 mitogen-activated protein kinase signaling. Mol Cell Biochem. 2020;475(1\u20132):249\u201360. https:\/\/doi.org\/10.1007\/s11010-020-03878-5.","journal-title":"Mol Cell Biochem"},{"issue":"4","key":"477_CR134","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1161\/circresaha.110.233999","volume":"108","author":"A Tsaousi","year":"2011","unstructured":"Tsaousi A, Williams H, Lyon CA, Taylor V, Swain A, Johnson JL, et al. Wnt4\/\u03b2-catenin signaling induces VSMC proliferation and is associated with intimal thickening. Circ Res. 2011;108(4):427\u201336. https:\/\/doi.org\/10.1161\/circresaha.110.233999.","journal-title":"Circ Res"},{"issue":"9","key":"477_CR135","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23122","volume":"36","author":"L Tang","year":"2022","unstructured":"Tang L, Wang N, Wei X, Huang S, Wang P, Zheng Y, et al. Cysteine and glycine-rich protein 2 promotes hypoxic pulmonary vascular smooth muscle cell proliferation through the Wnt3\u03b1-\u03b2-catenin\/lymphoid enhancer-binding factor 1 pathway. J Biochem Mol Toxicol. 2022;36(9):e23122. https:\/\/doi.org\/10.1002\/jbt.23122.","journal-title":"J Biochem Mol Toxicol"},{"issue":"2","key":"477_CR136","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/cbin.10543","volume":"40","author":"Y Zhuang","year":"2016","unstructured":"Zhuang Y, Mao JQ, Yu M, Dong LY, Fan YL, Lv ZQ, et al. Hyperlipidemia induces vascular smooth muscle cell proliferation involving Wnt\/\u03b2-catenin signaling. Cell Biol Int. 2016;40(2):121\u201330. https:\/\/doi.org\/10.1002\/cbin.10543.","journal-title":"Cell Biol Int"},{"issue":"2","key":"477_CR137","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1139\/bcb-2019-0249","volume":"98","author":"Q Xue","year":"2020","unstructured":"Xue Q, Wang X, Deng X, Huang Y, Tian W. CEMIP regulates the proliferation and migration of vascular smooth muscle cells in atherosclerosis through the WNT-beta-catenin signaling pathway. Biochem Cell Biol. 2020;98(2):249\u201357. https:\/\/doi.org\/10.1139\/bcb-2019-0249.","journal-title":"Biochem Cell Biol"},{"issue":"2","key":"477_CR138","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1093\/cvr\/cvab056","volume":"118","author":"W An","year":"2022","unstructured":"An W, Luong LA, Bowden NP, Yang M, Wu W, Zhou X, et al. Cezanne is a critical regulator of pathological arterial remodelling by targeting \u03b2-catenin signalling. Cardiovasc Res. 2022;118(2):638\u201353. https:\/\/doi.org\/10.1093\/cvr\/cvab056.","journal-title":"Cardiovasc Res"},{"issue":"2","key":"477_CR139","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00223-021-00833-4","volume":"109","author":"J Cong","year":"2021","unstructured":"Cong J, Cheng B, Liu J, He P. RTEF-1 inhibits vascular smooth muscle cell calcification through regulating Wnt\/\u03b2-Catenin signaling pathway. Calcif Tissue Int. 2021;109(2):203\u201314. https:\/\/doi.org\/10.1007\/s00223-021-00833-4.","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"477_CR140","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0089525","volume":"9","author":"A Montes de Oca","year":"2014","unstructured":"Montes de Oca A, Guerrero F, Martinez-Moreno JM, Madue\u00f1o JA, Herencia C, Peralta A, et al. Magnesium inhibits Wnt\/\u03b2-catenin activity and reverses the osteogenic transformation of vascular smooth muscle cells. PLoS ONE. 2014;9(2):e89525. https:\/\/doi.org\/10.1371\/journal.pone.0089525.","journal-title":"PLoS ONE"},{"key":"477_CR141","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/318714","volume":"2014","author":"C Caliceti","year":"2014","unstructured":"Caliceti C, Nigro P, Rizzo P, Ferrari R. ROS, Notch, and Wnt signaling pathways: crosstalk between three major regulators of cardiovascular biology. Biomed Res Int. 2014;2014:318714. https:\/\/doi.org\/10.1155\/2014\/318714.","journal-title":"Biomed Res Int"},{"issue":"5","key":"477_CR142","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.cellsig.2016.02.011","volume":"28","author":"DM DiRenzo","year":"2016","unstructured":"DiRenzo DM, Chaudhary MA, Shi X, Franco SR, Zent J, Wang K, et al. A crosstalk between TGF-\u03b2\/Smad3 and Wnt\/\u03b2-catenin pathways promotes vascular smooth muscle cell proliferation. Cell Signal. 2016;28(5):498\u2013505. https:\/\/doi.org\/10.1016\/j.cellsig.2016.02.011.","journal-title":"Cell Signal"},{"issue":"1","key":"477_CR143","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12964-024-01623-9","volume":"22","author":"DB Gumede","year":"2024","unstructured":"Gumede DB, Abrahamse H, Houreld NN. Targeting Wnt\/\u03b2-catenin signaling and its interplay with TGF-\u03b2 and Notch signaling pathways for the treatment of chronic wounds. Cell Commun Signal. 2024;22(1):244. https:\/\/doi.org\/10.1186\/s12964-024-01623-9.","journal-title":"Cell Commun Signal"},{"issue":"2","key":"477_CR144","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1161\/01.RES.0000175241.92285.f8","volume":"97","author":"AT Naito","year":"2005","unstructured":"Naito AT, Akazawa H, Takano H, Minamino T, Nagai T, Aburatani H, et al. Phosphatidylinositol 3-kinase-Akt pathway plays a critical role in early cardiomyogenesis by regulating canonical Wnt signaling. Circ Res. 2005;97(2):144\u201351. https:\/\/doi.org\/10.1161\/01.RES.0000175241.92285.f8.","journal-title":"Circ Res"},{"issue":"11","key":"477_CR145","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adg9278","volume":"10","author":"GH Oliveira-Paula","year":"2024","unstructured":"Oliveira-Paula GH, Liu S, Maira A, Ressa G, Ferreira GC, Quintar A, et al. The \u03b2-catenin C terminus links Wnt and sphingosine-1-phosphate signaling pathways to promote vascular remodeling and atherosclerosis. Sci Adv. 2024;10(11):eadg9278. https:\/\/doi.org\/10.1126\/sciadv.adg9278.","journal-title":"Sci Adv"},{"issue":"5","key":"477_CR146","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1161\/atvbaha.116.308643","volume":"37","author":"DF Riascos-Bernal","year":"2017","unstructured":"Riascos-Bernal DF, Chinnasamy P, Gross JN, Almonte V, Ega\u00f1a-Gorro\u00f1o L, Parikh D, et al. Inhibition of Smooth Muscle \u03b2-Catenin Hinders Neointima Formation After Vascular Injury. Arterioscler Thromb Vasc Biol. 2017;37(5):879\u201388. https:\/\/doi.org\/10.1161\/atvbaha.116.308643.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"477_CR147","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s10557-022-07362-8","volume":"37","author":"W Cheng","year":"2023","unstructured":"Cheng W, Cui C, Liu G, Ye C, Shao F, Bagchi AK, et al. NF-\u03baB, A Potential Therapeutic Target in Cardiovascular Diseases. Cardiovasc Drugs Ther. 2023;37(3):571\u201384. https:\/\/doi.org\/10.1007\/s10557-022-07362-8.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"1","key":"477_CR148","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/s0021-9150(96)06767-6","volume":"131","author":"B Cercek","year":"1997","unstructured":"Cercek B, Yamashita M, Dimayuga P, Zhu J, Fishbein MC, Kaul S, et al. Nuclear factor-kappaB activity and arterial response to balloon injury. Atherosclerosis. 1997;131(1):59\u201366. https:\/\/doi.org\/10.1016\/s0021-9150(96)06767-6.","journal-title":"Atherosclerosis"},{"issue":"6","key":"477_CR149","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1159\/000028039","volume":"66","author":"V Lindner","year":"1998","unstructured":"Lindner V. The NF-kappaB and IkappaB system in injured arteries. Pathobiol J Immunopathol Mol Cell Biol. 1998;66(6):311\u201320. https:\/\/doi.org\/10.1159\/000028039.","journal-title":"Pathobiol J Immunopathol Mol Cell Biol"},{"issue":"10","key":"477_CR150","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1096\/fj.04-2645fje","volume":"19","author":"DX Bu","year":"2005","unstructured":"Bu DX, Erl W, de Martin R, Hansson GK, Yan ZQ. IKKbeta-dependent NF-kappaB pathway controls vascular inflammation and intimal hyperplasia. FASEB J Official Publ Federation Am Soc Exp Biol. 2005;19(10):1293\u20135. https:\/\/doi.org\/10.1096\/fj.04-2645fje.","journal-title":"FASEB J Official Publ Federation Am Soc Exp Biol"},{"issue":"7","key":"477_CR151","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1089\/ars.2008.2393","volume":"11","author":"Y Castier","year":"2009","unstructured":"Castier Y, Ramkhelawon B, Riou S, Tedgui A, Lehoux S. Role of NF-kappaB in flow-induced vascular remodeling. Antioxid Redox Signal. 2009;11(7):1641\u20139. https:\/\/doi.org\/10.1089\/ars.2008.2393.","journal-title":"Antioxid Redox Signal"},{"issue":"5","key":"477_CR152","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1161\/atvbaha.115.307031","volume":"36","author":"JY Sun","year":"2016","unstructured":"Sun JY, Li C, Shen ZX, Zhang WC, Ai TJ, Du LJ, et al. Mineralocorticoid Receptor Deficiency in Macrophages Inhibits Neointimal Hyperplasia and Suppresses Macrophage Inflammation Through SGK1-AP1\/NF-\u03baB Pathways. Arterioscler Thromb Vasc Biol. 2016;36(5):874\u201385. https:\/\/doi.org\/10.1161\/atvbaha.115.307031.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"477_CR153","doi-asserted-by":"publisher","DOI":"10.3390\/genes15020197","author":"J Cornice","year":"2024","unstructured":"Cornice J, Verzella D, Arboretto P, Vecchiotti D, Capece D, Zazzeroni F, et al. NF-\u03baB: governing macrophages in cancer. Genes. 2024. https:\/\/doi.org\/10.3390\/genes15020197.","journal-title":"Genes"},{"issue":"3","key":"477_CR154","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.113.000230","volume":"2","author":"T Yoshida","year":"2013","unstructured":"Yoshida T, Yamashita M, Horimai C, Hayashi M. Smooth muscle-selective inhibition of nuclear factor-\u03baB attenuates smooth muscle phenotypic switching and neointima formation following vascular injury. J Am Heart Assoc. 2013;2(3):e000230. https:\/\/doi.org\/10.1161\/jaha.113.000230.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"477_CR155","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1093\/nar\/gks916","volume":"41","author":"E Ziesch\u00e9","year":"2013","unstructured":"Ziesch\u00e9 E, Kettner-Buhrow D, Weber A, Wittwer T, Jurida L, Soelch J, et al. The coactivator role of histone deacetylase 3 in IL-1-signaling involves deacetylation of p65 NF-\u03baB. Nucleic Acids Res. 2013;41(1):90\u2013109. https:\/\/doi.org\/10.1093\/nar\/gks916.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"477_CR156","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13731","volume":"58","author":"R He","year":"2025","unstructured":"He R, He Z, Zhang T, Liu B, Gao M, Li N, et al. HDAC3 in action: expanding roles in inflammation and inflammatory diseases. Cell Prolif. 2025;58(1):e13731. https:\/\/doi.org\/10.1111\/cpr.13731.","journal-title":"Cell Prolif"},{"issue":"3","key":"477_CR157","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/tox.23696","volume":"38","author":"D Chen","year":"2023","unstructured":"Chen D, Du Y, Ye S, Yu J. Astragaloside IV protects against oxidized low-density lipoprotein-induced injury in human umbilical vein endothelial cells via the histone deacetylase 9 (HDAC9)\/NF-\u03baB axis. Environ Toxicol. 2023;38(3):534\u201344. https:\/\/doi.org\/10.1002\/tox.23696.","journal-title":"Environ Toxicol"},{"issue":"1","key":"477_CR158","doi-asserted-by":"publisher","first-page":"H458","DOI":"10.1152\/ajpheart.00366.2020","volume":"320","author":"BW Wu","year":"2021","unstructured":"Wu BW, Wu MS, Liu Y, Lu M, Guo JD, Meng YH, et al. SIRT1-mediated deacetylation of NF-\u03baB inhibits the MLCK\/MLC2 pathway and the expression of ET-1, thus alleviating the development of coronary artery spasm. Am J Physiol Heart Circ Physiol. 2021;320(1):H458\u201368. https:\/\/doi.org\/10.1152\/ajpheart.00366.2020.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5","key":"477_CR159","doi-asserted-by":"publisher","first-page":"144","DOI":"10.14715\/cmb\/2021.67.5.20","volume":"67","author":"X Kong","year":"2022","unstructured":"Kong X, Chen H, Li D, Ma L. Effects of imbalance of lipid metabolism through NF-KB pathway on atherosclerosis and vascular aging in rats. Cell Mol Biol (Noisy-le-Grand). 2022;67(5):144\u201350. https:\/\/doi.org\/10.14715\/cmb\/2021.67.5.20.","journal-title":"Cell Mol Biol (Noisy-le-Grand)"},{"issue":"1","key":"477_CR160","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-31885-1","volume":"13","author":"A Reicherz","year":"2023","unstructured":"Reicherz A, Eltit F, Scotland K, Almutairi K, Bell R, Mojtahedzadeh B, et al. Indwelling stents cause severe inflammation and fibrosis of the ureter via urothelial-mesenchymal transition. Sci Rep. 2023;13(1):5492. https:\/\/doi.org\/10.1038\/s41598-023-31885-1.","journal-title":"Sci Rep"},{"issue":"8","key":"477_CR161","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-023-04840-6","volume":"80","author":"Y Bai","year":"2023","unstructured":"Bai Y, Zhang L, Zheng B, Zhang X, Zhang H, Zhao A, et al. circACTA2 inhibits NLRP3 inflammasome-mediated inflammation via interacting with NF-\u03baB in vascular smooth muscle cells. Cell Mol Life Sci CMLS. 2023;80(8):229. https:\/\/doi.org\/10.1007\/s00018-023-04840-6.","journal-title":"Cell Mol Life Sci CMLS"},{"key":"477_CR162","doi-asserted-by":"publisher","unstructured":"Han B, Wang G, Forum JHJTHS. P65\/NLRP3 Inflammasome Mediated Endothelial Cells Pyroptosis: A Novel Mechanism of In-Stent Restenosis. 2024;10 3. https:\/\/doi.org\/10.59958\/hsf.6845.","DOI":"10.59958\/hsf.6845"},{"key":"477_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113803","volume":"145","author":"Y Wang","year":"2025","unstructured":"Wang Y, Ge J, Dou M, Cheng X, Chen X, Ma L, et al. Inhibition of CCR2 attenuates NLRP3-dependent pyroptosis after myocardial ischaemia-reperfusion in rats via the NF-kB pathway. Int Immunopharmacol. 2025;145:113803. https:\/\/doi.org\/10.1016\/j.intimp.2024.113803.","journal-title":"Int Immunopharmacol"},{"issue":"8","key":"477_CR164","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1179\/016164104x5110","volume":"26","author":"J Garc\u00eda-Trapero","year":"2004","unstructured":"Garc\u00eda-Trapero J, Carceller F, Dujovny M, Cuevas P. Perivascular delivery of neomycin inhibits the activation of NF-\u03baB and MAPK pathways, and prevents neointimal hyperplasia and stenosis after arterial injury. Neurol Res. 2004;26(8):816\u201324. https:\/\/doi.org\/10.1179\/016164104x5110.","journal-title":"Neurol Res"},{"issue":"3","key":"477_CR165","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1253\/circj.68.270","volume":"68","author":"J-I S","year":"2004","unstructured":"S J-I, I H, G R, M R, E K, I M. Initial clinical cases of the use of a NF-kappaB decoy at the site of coronary stenting for the prevention of restenosis. Circ J. 2004;68(3):270\u20131. https:\/\/doi.org\/10.1253\/circj.68.270.","journal-title":"Circ J"},{"issue":"25","key":"477_CR166","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1161\/circulationaha.105.582254","volume":"114","author":"K Ohtani","year":"2006","unstructured":"Ohtani K, Egashira K, Nakano K, Zhao G, Funakoshi K, Ihara Y, et al. Stent-based local delivery of nuclear factor-kappaB decoy attenuates in-stent restenosis in hypercholesterolemic rabbits. Circulation. 2006;114(25):2773\u20139. https:\/\/doi.org\/10.1161\/circulationaha.105.582254.","journal-title":"Circulation"},{"issue":"1","key":"477_CR167","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/s12944-018-0921-3","volume":"17","author":"R Zhang","year":"2018","unstructured":"Zhang R, Li T, Guo J, Zhao Y, Liu Y, Yao Y, et al. Fufang-Zhenzhu-Tiaozhi Capsule reduces restenosis via the downregulation of NF-kappaB and inflammatory factors in rabbits. Lipids Health Dis. 2018;17(1):272. https:\/\/doi.org\/10.1186\/s12944-018-0921-3.","journal-title":"Lipids Health Dis"},{"key":"477_CR168","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrep.2022.101394","volume":"33","author":"J Yuan","year":"2023","unstructured":"Yuan J, Kong Y. MiR-7-5p attenuates vascular smooth muscle cell migration and intimal hyperplasia after vascular injury by NF-kB signaling. Biochem Biophys Rep. 2023;33:101394. https:\/\/doi.org\/10.1016\/j.bbrep.2022.101394.","journal-title":"Biochem Biophys Rep"},{"issue":"1","key":"477_CR169","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s13105-020-00779-5","volume":"77","author":"Y Jiao","year":"2021","unstructured":"Jiao Y, Zhao D, Gao F, Hu X, Hu X, Li M, et al. MicroRNA-520c-3p suppresses vascular endothelium dysfunction by targeting RELA and regulating the AKT and NF-\u03baB signaling pathways. J Physiol Biochem. 2021;77(1):47\u201361. https:\/\/doi.org\/10.1007\/s13105-020-00779-5.","journal-title":"J Physiol Biochem"},{"issue":"8","key":"477_CR170","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1111\/bph.13806","volume":"175","author":"J He","year":"2018","unstructured":"He J, Bao Q, Yan M, Liang J, Zhu Y, Wang C, et al. The role of Hippo\/yes-associated protein signalling in vascular remodelling associated with cardiovascular disease. Br J Pharmacol. 2018;175(8):1354\u201361. https:\/\/doi.org\/10.1111\/bph.13806.","journal-title":"Br J Pharmacol"},{"issue":"16","key":"477_CR171","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.2174\/1381612828666220428090540","volume":"28","author":"XY Liu","year":"2022","unstructured":"Liu XY, Zhou K, Tian KJ, Yan BJ, Ren Z, Zhou ZX, et al. Hippo: A New Hub for Atherosclerotic Disease. Curr Pharm Des. 2022;28(16):1321\u20138. https:\/\/doi.org\/10.2174\/1381612828666220428090540.","journal-title":"Curr Pharm Des"},{"key":"477_CR172","doi-asserted-by":"publisher","first-page":"204201882312201","DOI":"10.1177\/20420188231220134","volume":"14","author":"L Wei","year":"2023","unstructured":"Wei L, Gao J, Wang L, Tao Q, Tu C. Hippo\/YAP signaling pathway: a new therapeutic target for diabetes mellitus and vascular complications. Ther Adv Endocrinol Metab. 2023;14:20420188231220136. https:\/\/doi.org\/10.1177\/20420188231220134.","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"7634","key":"477_CR173","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nature20602","volume":"540","author":"L Wang","year":"2016","unstructured":"Wang L, Luo JY, Li B, Tian XY, Chen LJ, Huang Y, et al. Integrin-YAP\/TAZ-JNK cascade mediates atheroprotective effect of unidirectional shear flow. Nature. 2016;540(7634):579\u201382. https:\/\/doi.org\/10.1038\/nature20602.","journal-title":"Nature"},{"issue":"3","key":"477_CR174","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s10735-025-10443-1","volume":"56","author":"J Bai","year":"2025","unstructured":"Bai J, Yang Y. Activation of Hippo\/YAP signaling pathway exacerbates vascular remodeling and aggravates hypertension by upregulating Foxm1. J Mol Histol. 2025;56(3):158. https:\/\/doi.org\/10.1007\/s10735-025-10443-1.","journal-title":"J Mol Histol"},{"issue":"5","key":"477_CR175","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/cbin.11120","volume":"43","author":"J Hu","year":"2019","unstructured":"Hu J, Liu T, Zhang Z, Xu Y, Zhu F. Oxidized low-density lipoprotein promotes vascular endothelial cell dysfunction by stimulating miR-496 expression and inhibiting the Hippo pathway effector YAP. Cell Biol Int. 2019;43(5):528\u201338. https:\/\/doi.org\/10.1002\/cbin.11120.","journal-title":"Cell Biol Int"},{"issue":"11","key":"477_CR176","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.1060","volume":"11","author":"H Liu","year":"2023","unstructured":"Liu H, Sun M, Wu N, Liu B, Liu Q, Fan X. TGF-\u03b2\/Smads signaling pathway, Hippo-YAP\/TAZ signaling pathway, and VEGF: Their mechanisms and roles in vascular remodeling related diseases. Immun Inflam Dis. 2023;11(11):e1060. https:\/\/doi.org\/10.1002\/iid3.1060.","journal-title":"Immun Inflam Dis"},{"key":"477_CR177","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yjmcc.2015.11.024","volume":"90","author":"TE Kimura","year":"2016","unstructured":"Kimura TE, Duggirala A, Smith MC, White S, Sala-Newby GB, Newby AC, et al. The Hippo pathway mediates inhibition of vascular smooth muscle cell proliferation by cAMP. J Mol Cell Cardiol. 2016;90:1\u201310. https:\/\/doi.org\/10.1016\/j.yjmcc.2015.11.024.","journal-title":"J Mol Cell Cardiol"},{"issue":"6","key":"477_CR178","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12517","volume":"51","author":"M Lin","year":"2018","unstructured":"Lin M, Yuan W, Su Z, Lin C, Huang T, Chen Y, et al. Yes-associated protein mediates angiotensin II-induced vascular smooth muscle cell phenotypic modulation and hypertensive vascular remodelling. Cell Prolif. 2018;51(6):e12517. https:\/\/doi.org\/10.1111\/cpr.12517.","journal-title":"Cell Prolif"},{"key":"477_CR179","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.110613","volume":"105","author":"XY Luo","year":"2023","unstructured":"Luo XY, Fu X, Liu F, Luo JY, Chen AF. Sema3G activates YAP and promotes VSMCs proliferation and migration via Nrp2\/PlexinA1. Cell Signal. 2023;105:110613. https:\/\/doi.org\/10.1016\/j.cellsig.2023.110613.","journal-title":"Cell Signal"},{"issue":"3","key":"477_CR180","doi-asserted-by":"publisher","first-page":"H541","DOI":"10.1152\/ajpheart.00089.2019","volume":"317","author":"C Huang","year":"2019","unstructured":"Huang C, Zhang W, Zhu Y. Drug-eluting stent specifically designed to target vascular smooth muscle cell phenotypic modulation attenuated restenosis through the YAP pathway. Am J Physiol Heart Circ Physiol. 2019;317(3):H541\u201351. https:\/\/doi.org\/10.1152\/ajpheart.00089.2019.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"477_CR181","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.cmet.2018.07.010","volume":"28","author":"JH Koo","year":"2018","unstructured":"Koo JH, Guan KL. Interplay between YAP\/TAZ and metabolism. Cell Metab. 2018;28(2):196\u2013206. https:\/\/doi.org\/10.1016\/j.cmet.2018.07.010.","journal-title":"Cell Metab"},{"issue":"3","key":"477_CR182","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s10456-020-09760-8","volume":"24","author":"Y Feng","year":"2021","unstructured":"Feng Y, Zou R, Zhang X, Shen M, Chen X, Wang J, et al. YAP promotes ocular neovascularization by modifying PFKFB3-driven endothelial glycolysis. Angiogenesis. 2021;24(3):489\u2013504. https:\/\/doi.org\/10.1007\/s10456-020-09760-8.","journal-title":"Angiogenesis"},{"issue":"3","key":"477_CR183","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.7150\/thno.98660","volume":"15","author":"Y Li","year":"2025","unstructured":"Li Y, Chen X, Xu X, Chen C, Min M, Liang D, et al. OTUB2 contributes to vascular calcification in chronic kidney disease via the YAP-mediated transcription of PFKFB3. Theranostics. 2025;15(3):1185\u2013204. https:\/\/doi.org\/10.7150\/thno.98660.","journal-title":"Theranostics"},{"issue":"16","key":"477_CR184","doi-asserted-by":"publisher","first-page":"7956","DOI":"10.7150\/thno.113303","volume":"15","author":"P Weng","year":"2025","unstructured":"Weng P, Wen Y, Yuan Z, Ma L, Yang L, Li C, et al. O-GlcNAcylation-dependent liquid-liquid phase separation regulates the nuclear translocation of YAP to exacerbate vascular neointimal hyperplasia. Theranostics. 2025;15(16):7956\u201372. https:\/\/doi.org\/10.7150\/thno.113303.","journal-title":"Theranostics"},{"issue":"7","key":"477_CR185","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.124.037531","volume":"14","author":"G Garoffolo","year":"2025","unstructured":"Garoffolo G, Sluiter TJ, Thomas A, Piacentini L, Ruiter MS, Schiavo A, et al. Blockade of YAP Mechanoactivation Prevents Neointima Formation and Adverse Remodeling in Arterialized Vein Grafts. J Am Heart Assoc. 2025;14(7):e037531. https:\/\/doi.org\/10.1161\/jaha.124.037531.","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"477_CR186","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1007\/s11010-024-05160-4","volume":"480","author":"P Zhang","year":"2025","unstructured":"Zhang P, Xu C, Liu Z, Geng Y, Liu H. Unleashing the therapeutic power of verteporfin-eluting stents: modulating YAP signaling to combat carotid artery restenosis and cerebral watershed infarction. Mol Cell Biochem. 2025;480(5):2951\u201370. https:\/\/doi.org\/10.1007\/s11010-024-05160-4.","journal-title":"Mol Cell Biochem"},{"issue":"4","key":"477_CR187","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1165\/rcmb.2019-0296OC","volume":"62","author":"DM Santos","year":"2020","unstructured":"Santos DM, Pantano L, Pronzati G, Grasberger P, Probst CK, Black KE, et al. Screening for YAP Inhibitors Identifies Statins as Modulators of Fibrosis. Am J Respir Cell Mol Biol. 2020;62(4):479\u201392. https:\/\/doi.org\/10.1165\/rcmb.2019-0296OC.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"477_CR188","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.170845","author":"M Ar\u00e9valo Mart\u00ednez","year":"2023","unstructured":"Ar\u00e9valo Mart\u00ednez M, Ritsvall O, Bastrup JA, Celik S, Jakobsson G, Daoud F, et al. Vascular smooth muscle-specific YAP\/TAZ deletion triggers aneurysm development in mouse aorta. JCI Insight. 2023. https:\/\/doi.org\/10.1172\/jci.insight.170845.","journal-title":"JCI Insight"},{"issue":"9","key":"477_CR189","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202154401","volume":"23","author":"PJY Toh","year":"2022","unstructured":"Toh PJY, Lai JKH, Hermann A, Destaing O, Sheetz MP, Sudol M, et al. Optogenetic control of YAP cellular localisation and function. EMBO Rep. 2022;23(9):e54401. https:\/\/doi.org\/10.15252\/embr.202154401.","journal-title":"EMBO Rep"},{"key":"477_CR190","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27020983","author":"E M\u0142ynarska","year":"2026","unstructured":"M\u0142ynarska E, Bojdo K, Bulicz A, Hossa K, Lisi\u0144ska W, Stasiak P, et al. Epigenetic regulation and molecular mechanisms in cardiovascular diseases: a review of recent advances and therapeutic implications. Int J Mol Sci. 2026. https:\/\/doi.org\/10.3390\/ijms27020983.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"477_CR191","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1089\/dna.2022.0278","volume":"41","author":"Y Chen","year":"2022","unstructured":"Chen Y, Liang L, Wu C, Cao Z, Xia L, Meng J, et al. Epigenetic Control of Vascular Smooth Muscle Cell Function in Atherosclerosis: A Role for DNA Methylation. DNA Cell Biol. 2022;41(9):824\u201337. https:\/\/doi.org\/10.1089\/dna.2022.0278.","journal-title":"DNA Cell Biol"},{"key":"477_CR192","doi-asserted-by":"publisher","unstructured":"Richards J, Ogoe HA, Li W, Babayewa O, Xu W, Bythwood T et al. DNA Methylation Signature of Post-injury Neointimal Cells During Vascular Remodeling in the Rat Balloon Injury Model. Mol Biol (Los Angeles, Calif). 2016;5(3). https:\/\/doi.org\/10.4172\/2168-9547.1000163.","DOI":"10.4172\/2168-9547.1000163"},{"issue":"1","key":"477_CR193","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1161\/atvbaha.116.307923","volume":"37","author":"J Zhuang","year":"2017","unstructured":"Zhuang J, Luan P, Li H, Wang K, Zhang P, Xu Y, et al. The Yin-Yang dynamics of DNA methylation is the key regulator for smooth muscle cell phenotype switch and vascular remodeling. Arterioscler Thromb Vasc Biol. 2017;37(1):84\u201397. https:\/\/doi.org\/10.1161\/atvbaha.116.307923.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"477_CR194","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1161\/atvbaha.125.322645","volume":"45","author":"CH Kong","year":"2025","unstructured":"Kong CH, Sun Y, Wu LD, Zhou WY, Wang DC, Jiang ZH, et al. GRK2 orchestrates VSMC phenotypic modulation via DNMT1-mediated DNA methylation reprogramming. Arterioscler Thromb Vasc Biol. 2025;45(10):1818\u201334. https:\/\/doi.org\/10.1161\/atvbaha.125.322645.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"477_CR195","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1139\/cjpp-2018-0111","volume":"96","author":"CS Boosani","year":"2018","unstructured":"Boosani CS, Gunasekar P, Block M, Jiang W, Zhang Z, Radwan MM, et al. Inhibition of DNA methyltransferase-1 instigates the expression of DNA methyltransferase-3a in angioplasty-induced restenosis. Can J Physiol Pharmacol. 2018;96(10):1030\u20139. https:\/\/doi.org\/10.1139\/cjpp-2018-0111.","journal-title":"Can J Physiol Pharmacol"},{"issue":"18","key":"477_CR196","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1161\/circulationaha.113.002887","volume":"128","author":"R Liu","year":"2013","unstructured":"Liu R, Jin Y, Tang WH, Qin L, Zhang X, Tellides G, et al. Ten-eleven translocation-2 (TET2) is a master regulator of smooth muscle cell plasticity. Circulation. 2013;128(18):2047\u201357. https:\/\/doi.org\/10.1161\/circulationaha.113.002887.","journal-title":"Circulation"},{"issue":"6","key":"477_CR197","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1161\/circulationaha.120.050553","volume":"144","author":"AC Ostriker","year":"2021","unstructured":"Ostriker AC, Xie Y, Chakraborty R, Sizer AJ, Bai Y, Ding M, et al. TET2 protects against vascular smooth muscle cell apoptosis and intimal thickening in transplant vasculopathy. Circulation. 2021;144(6):455\u201370. https:\/\/doi.org\/10.1161\/circulationaha.120.050553.","journal-title":"Circulation"},{"issue":"5","key":"477_CR198","doi-asserted-by":"publisher","first-page":"207","DOI":"10.21037\/atm-22-4371","volume":"11","author":"L Chen","year":"2023","unstructured":"Chen L, He J, Zhang Y, Li Y, Zhang T, Wang R, et al. Regulation of endothelial-to-mesenchymal transition by histone deacetylase 3 posttranslational modifications in neointimal hyperplasia. Ann Transl Med. 2023;11(5):207. https:\/\/doi.org\/10.21037\/atm-22-4371.","journal-title":"Ann Transl Med"},{"issue":"11","key":"477_CR199","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.1161\/atvbaha.111.230888","volume":"31","author":"B Zhou","year":"2011","unstructured":"Zhou B, Margariti A, Zeng L, Habi O, Xiao Q, Martin D, et al. Splicing of histone deacetylase 7 modulates smooth muscle cell proliferation and neointima formation through nuclear \u03b2-catenin translocation. Arterioscler Thromb Vasc Biol. 2011;31(11):2676\u201384. https:\/\/doi.org\/10.1161\/atvbaha.111.230888.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"23","key":"477_CR200","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1161\/circulationaha.121.057599","volume":"145","author":"R Chakraborty","year":"2022","unstructured":"Chakraborty R, Ostriker AC, Xie Y, Dave JM, Gamez-Mendez A, Chatterjee P, et al. Histone Acetyltransferases p300 and CBP Coordinate Distinct Chromatin Remodeling Programs in Vascular Smooth Muscle Plasticity. Circulation. 2022;145(23):1720\u201337. https:\/\/doi.org\/10.1161\/circulationaha.121.057599.","journal-title":"Circulation"},{"issue":"4","key":"477_CR201","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1161\/atvbaha.110.221952","volume":"31","author":"HM Findeisen","year":"2011","unstructured":"Findeisen HM, Gizard F, Zhao Y, Qing H, Heywood EB, Jones KL, et al. Epigenetic regulation of vascular smooth muscle cell proliferation and neointima formation by histone deacetylase inhibition. Arterioscler Thromb Vasc Biol. 2011;31(4):851\u201360. https:\/\/doi.org\/10.1161\/atvbaha.110.221952.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"477_CR202","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.70077","volume":"58","author":"LY Zhang","year":"2025","unstructured":"Zhang LY, Wang YY, Wen R, Zhang TN, Yang N. Role of Histone Deacetylase and Inhibitors in Cardiovascular Diseases. Cell Prolif. 2025;58(12):e70077. https:\/\/doi.org\/10.1111\/cpr.70077.","journal-title":"Cell Prolif"},{"issue":"1","key":"477_CR203","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13148-020-00826-4","volume":"12","author":"X Wei","year":"2020","unstructured":"Wei X, Yi X, Zhu XH, Jiang DS. Histone methylation and vascular biology. Clin Epigenetics. 2020;12(1):30. https:\/\/doi.org\/10.1186\/s13148-020-00826-4.","journal-title":"Clin Epigenetics"},{"key":"477_CR204","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11020103","author":"J Fledderus","year":"2021","unstructured":"Fledderus J, Vanchin B, Rots MG, Krenning G. The endothelium as a target for anti-atherogenic therapy: a focus on the epigenetic enzymes EZH2 and SIRT1. J Pers Med. 2021. https:\/\/doi.org\/10.3390\/jpm11020103.","journal-title":"J Pers Med"},{"issue":"1","key":"477_CR205","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12711","volume":"53","author":"X Zhang","year":"2020","unstructured":"Zhang X, Huang T, Zhai H, Peng W, Zhou Y, Li Q, et al. Inhibition of lysine-specific demethylase 1A suppresses neointimal hyperplasia by targeting bone morphogenetic protein 2 and mediating vascular smooth muscle cell phenotype. Cell Prolif. 2020;53(1):e12711. https:\/\/doi.org\/10.1111\/cpr.12711.","journal-title":"Cell Prolif"},{"issue":"1","key":"477_CR206","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13148-022-01321-8","volume":"14","author":"Y He","year":"2022","unstructured":"He Y, Yi X, Zhang Z, Luo H, Li R, Feng X, et al. JIB-04, a histone demethylase Jumonji C domain inhibitor, regulates phenotypic switching of vascular smooth muscle cells. Clin Epigenetics. 2022;14(1):101. https:\/\/doi.org\/10.1186\/s13148-022-01321-8.","journal-title":"Clin Epigenetics"},{"issue":"3","key":"477_CR207","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1161\/circulationaha.125.072576","volume":"153","author":"L Liu","year":"2026","unstructured":"Liu L, Zhang J, Dong Z, Cui Y, Zou X, Lai H, et al. Histone Lactylation-Mediated Metabolic Remodeling in Vascular Smooth Muscle Cells Aggravates Aortic Aneurysm and Dissection by Promoting Lactate Accumulation. Circulation. 2026;153(3):189\u2013209. https:\/\/doi.org\/10.1161\/circulationaha.125.072576.","journal-title":"Circulation"},{"key":"477_CR208","doi-asserted-by":"publisher","DOI":"10.1016\/j.mvr.2023.104643","volume":"152","author":"W Feng","year":"2024","unstructured":"Feng W, Liang H, Liu D, Ruan S. The SNHG12\/microRNA-15b-5p\/MYLK axis regulates vascular smooth muscle cell phenotype to affect intracranial aneurysm formation. Microvasc Res. 2024;152:104643. https:\/\/doi.org\/10.1016\/j.mvr.2023.104643.","journal-title":"Microvasc Res"},{"issue":"2","key":"477_CR209","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3233\/ch-211166","volume":"80","author":"Y Yang","year":"2022","unstructured":"Yang Y, Mao W, Wang L, Lu L, Pang Y. Circular RNA circLMF1 regulates PDGF-BB-induced proliferation and migration of human aortic smooth muscle cells by regulating the miR-125a-3p\/VEGFA or FGF1 axis. Clin Hemorheol Microcirc. 2022;80(2):167\u201383. https:\/\/doi.org\/10.3233\/ch-211166.","journal-title":"Clin Hemorheol Microcirc"},{"key":"477_CR210","doi-asserted-by":"publisher","first-page":"1400780","DOI":"10.3389\/fcvm.2024.1400780","volume":"11","author":"Y Xin","year":"2024","unstructured":"Xin Y, Zhang Z, Lv S, Xu S, Liu A, Li H, et al. Elucidating VSMC phenotypic transition mechanisms to bridge insights into cardiovascular disease implications. Front Cardiovasc Med. 2024;11:1400780. https:\/\/doi.org\/10.3389\/fcvm.2024.1400780.","journal-title":"Front Cardiovasc Med"},{"issue":"9","key":"477_CR211","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2022.166450","volume":"1868","author":"Y Shen","year":"2022","unstructured":"Shen Y, Xu LR, Yan D, Zhou M, Han TL, Lu C, et al. BMAL1 modulates smooth muscle cells phenotypic switch towards fibroblast-like cells and stabilizes atherosclerotic plaques by upregulating YAP1. Biochim Biophys Acta. 2022;1868(9):166450. https:\/\/doi.org\/10.1016\/j.bbadis.2022.166450.","journal-title":"Biochim Biophys Acta"},{"key":"477_CR212","doi-asserted-by":"publisher","unstructured":"Mu\u00f1oz F, Holden CM, San Martin A. Beyond a Simple Switch: Decoding the Multifactorial Phenotypic Plasticity of Vascular Smooth Muscle Cells. Cells. 2025;14(15). https:\/\/doi.org\/10.3390\/cells14151171.","DOI":"10.3390\/cells14151171"},{"key":"477_CR213","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jare.2025.03.018","volume":"79","author":"Q Chen","year":"2026","unstructured":"Chen Q, Liu S, Zhou H, Wang J, Xiao X, Chen G, et al. SAMD4A inhibits abdominal aortic aneurysm development and VSMC phenotypic transformation through targeting KDM2B. J Adv Res. 2026;79:223\u201337. https:\/\/doi.org\/10.1016\/j.jare.2025.03.018.","journal-title":"J Adv Res"},{"issue":"4","key":"477_CR214","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1089\/ten.TEB.2024.0178","volume":"31","author":"MK Kang","year":"2025","unstructured":"Kang MK, Heo SH, Yoon JK. In-stent re-endothelialization strategies: cells, extracellular matrix, and extracellular vesicles. Tissue Eng Part B Rev. 2025;31(4):317\u201330. https:\/\/doi.org\/10.1089\/ten.TEB.2024.0178.","journal-title":"Tissue Eng Part B Rev"},{"issue":"1","key":"477_CR215","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s40824-022-00334-x","volume":"26","author":"SW Baek","year":"2022","unstructured":"Baek SW, Kim DS, Song DH, Kim HB, Lee S, Kim JH, et al. Reduced restenosis and enhanced re-endothelialization of functional biodegradable vascular scaffolds by everolimus and magnesium hydroxide. Biomater Res. 2022;26(1):86. https:\/\/doi.org\/10.1186\/s40824-022-00334-x.","journal-title":"Biomater Res"},{"key":"477_CR216","doi-asserted-by":"publisher","unstructured":"Haron NA, Ishak MF, Yazid MD, Vijakumaran U, Ibrahim R, Raja Sabudin RZA et al. Exploring the Potential of Saphenous Vein Grafts Ex Vivo: A Model for Intimal Hyperplasia and Re-Endothelialization. J Clin Med. 2024;13(16). https:\/\/doi.org\/10.3390\/jcm13164774.","DOI":"10.3390\/jcm13164774"},{"issue":"6","key":"477_CR217","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1096\/fj.01-0842com","volume":"16","author":"IB Buchwalow","year":"2002","unstructured":"Buchwalow IB, Podzuweit T, Bocker W, Samoilova VE, Thomas S, Wellner M, et al. Vascular smooth muscle and nitric oxide synthase. FASEB J. 2002;16(6):500\u20138. https:\/\/doi.org\/10.1096\/fj.01-0842com.","journal-title":"FASEB J"},{"issue":"4","key":"477_CR218","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.cardiores.2006.05.024","volume":"71","author":"JS Isenberg","year":"2006","unstructured":"Isenberg JS, Wink DA, Roberts DD. Thrombospondin-1 antagonizes nitric oxide-stimulated vascular smooth muscle cell responses. Cardiovasc Res. 2006;71(4):785\u201393. https:\/\/doi.org\/10.1016\/j.cardiores.2006.05.024.","journal-title":"Cardiovasc Res"},{"issue":"3","key":"477_CR219","doi-asserted-by":"publisher","first-page":"177","DOI":"10.4196\/kjpp.2010.14.3.177","volume":"14","author":"X Jiang","year":"2010","unstructured":"Jiang X, Kim B, Lin H, Lee CK, Kim J, Kang H, et al. Tetrahydrobiopterin Inhibits PDGF-stimulated Migration and Proliferation in Rat Aortic Smooth Muscle Cells via the Nitric Oxide Synthase-independent Pathway. Korean J Physiol Pharmacol Official J Korean Physiol Soc Korean Soc Pharmacol. 2010;14(3):177\u201383. https:\/\/doi.org\/10.4196\/kjpp.2010.14.3.177.","journal-title":"Korean J Physiol Pharmacol Official J Korean Physiol Soc Korean Soc Pharmacol"},{"issue":"1-2","key":"477_CR220","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s12013-011-9179-3","volume":"60","author":"ND Tsihlis","year":"2011","unstructured":"Tsihlis ND, Oustwani CS, Vavra AK, Jiang Q, Keefer LK, Kibbe MR. Nitric oxide inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia by increasing the ubiquitination and degradation of UbcH10. Cell Biochem Biophys. 2011;60(1\u20132):89\u201397. https:\/\/doi.org\/10.1007\/s12013-011-9179-3.","journal-title":"Cell Biochem Biophys"},{"key":"477_CR221","doi-asserted-by":"publisher","DOI":"10.1186\/2045-824x-3-21","volume":"3","author":"JF Schad","year":"2011","unstructured":"Schad JF, Meltzer KR, Hicks MR, Beutler DS, Cao TV, Standley PR. Cyclic strain upregulates VEGF and attenuates proliferation of vascular smooth muscle cells. Vasc Cell. 2011;3:21. https:\/\/doi.org\/10.1186\/2045-824x-3-21.","journal-title":"Vasc Cell"},{"issue":"1","key":"477_CR222","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1038\/s41598-017-02907-6","volume":"7","author":"XH Liao","year":"2017","unstructured":"Liao XH, Xiang Y, Li H, Zheng L, Xu Y, Xi YuC, et al. VEGF-A Stimulates STAT3 Activity via Nitrosylation of Myocardin to Regulate the Expression of Vascular Smooth Muscle Cell Differentiation Markers. Sci Rep. 2017;7(1):2660. https:\/\/doi.org\/10.1038\/s41598-017-02907-6.","journal-title":"Sci Rep"},{"key":"477_CR223","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/982458","volume":"2013","author":"R Schlich","year":"2013","unstructured":"Schlich R, Willems M, Greulich S, Ruppe F, Knoefel WT, Ouwens DM, et al. VEGF in the crosstalk between human adipocytes and smooth muscle cells: depot-specific release from visceral and perivascular adipose tissue. Mediators Inflamm. 2013;2013:982458. https:\/\/doi.org\/10.1155\/2013\/982458.","journal-title":"Mediators Inflamm"},{"issue":"20","key":"477_CR224","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1161\/01.cir.102.20.2522","volume":"102","author":"T Ito","year":"2000","unstructured":"Ito T, Ikeda U, Shimpo M, Yamamoto K, Shimada K. Serotonin increases Interleukin-6 synthesis in human vascular smooth muscle cells. Circulation. 2000;102(20):2522\u20137. https:\/\/doi.org\/10.1161\/01.cir.102.20.2522.","journal-title":"Circulation"},{"issue":"12","key":"477_CR225","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1007\/s00380-017-1054-8","volume":"32","author":"Z An","year":"2017","unstructured":"An Z, Qiao F, Lu Q, Ma Y, Liu Y, Lu F, et al. Interleukin-6 downregulated vascular smooth muscle cell contractile proteins via ATG4B-mediated autophagy in thoracic aortic dissection. Heart Vessels. 2017;32(12):1523\u201335. https:\/\/doi.org\/10.1007\/s00380-017-1054-8.","journal-title":"Heart Vessels"},{"issue":"11","key":"477_CR226","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202100943R","volume":"35","author":"I Cimmino","year":"2021","unstructured":"Cimmino I, Prisco F, Orso S, Agognon AL, Liguoro P, De Biase D, et al. Interleukin 6 reduces vascular smooth muscle cell apoptosis via Prep1 and is associated with aging. FASEB J. 2021;35(11):e21989. https:\/\/doi.org\/10.1096\/fj.202100943R.","journal-title":"FASEB J"},{"key":"477_CR227","doi-asserted-by":"publisher","unstructured":"M\u00e9ndez-Barbero N, Guti\u00e9rrez-Mu\u00f1oz C, Blanco-Colio LM. Cellular Crosstalk between Endothelial and Smooth Muscle Cells in Vascular Wall Remodeling. Int J Mol Sci. 2021;22(14). https:\/\/doi.org\/10.3390\/ijms22147284.","DOI":"10.3390\/ijms22147284"},{"key":"477_CR228","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.123319","volume":"361","author":"M Xie","year":"2025","unstructured":"Xie M, Li X, Chen L, Zhang Y, Chen L, Hua H, et al. The crosstalks between vascular endothelial cells, vascular smooth muscle cells, and adventitial fibroblasts in vascular remodeling. Life Sci. 2025;361:123319. https:\/\/doi.org\/10.1016\/j.lfs.2024.123319.","journal-title":"Life Sci"},{"issue":"8","key":"477_CR229","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.2217\/epi-2016-0009","volume":"8","author":"A Maiques-Diaz","year":"2016","unstructured":"Maiques-Diaz A, Somervaille TC. LSD1: biologic roles and therapeutic targeting. Epigenomics. 2016;8(8):1103\u201316. https:\/\/doi.org\/10.2217\/epi-2016-0009.","journal-title":"Epigenomics"},{"issue":"17","key":"477_CR230","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1007\/s00018-020-03489-9","volume":"77","author":"F Gu","year":"2020","unstructured":"Gu F, Lin Y, Wang Z, Wu X, Ye Z, Wang Y, et al. Biological roles of LSD1 beyond its demethylase activity. Cell Mol Life Sci CMLS. 2020;77(17):3341\u201350. https:\/\/doi.org\/10.1007\/s00018-020-03489-9.","journal-title":"Cell Mol Life Sci CMLS"},{"issue":"6","key":"477_CR231","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.21037\/tlcr-23-40","volume":"12","author":"M Sattler","year":"2023","unstructured":"Sattler M, Salgia R. LSD1-targeted therapy-a multi-purpose key to unlock immunotherapy in small cell lung cancer. Transl Lung Cancer Res. 2023;12(6):1350\u20134. https:\/\/doi.org\/10.21037\/tlcr-23-40.","journal-title":"Transl Lung Cancer Res"},{"issue":"2","key":"477_CR232","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/med.22000","volume":"44","author":"HM Liu","year":"2024","unstructured":"Liu HM, Zhou Y, Chen HX, Wu JW, Ji SK, Shen L, et al. LSD1 in drug discovery: From biological function to clinical application. Med Res Rev. 2024;44(2):833\u201366. https:\/\/doi.org\/10.1002\/med.22000.","journal-title":"Med Res Rev"},{"issue":"11","key":"477_CR233","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.4155\/fmc-2017-0068","volume":"9","author":"X Fu","year":"2017","unstructured":"Fu X, Zhang P, Yu B. Advances toward LSD1 inhibitors for cancer therapy. Future Med Chem. 2017;9(11):1227\u201342. https:\/\/doi.org\/10.4155\/fmc-2017-0068.","journal-title":"Future Med Chem"},{"issue":"1","key":"477_CR234","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-019-0811-9","volume":"12","author":"Y Fang","year":"2019","unstructured":"Fang Y, Liao G, Yu B. LSD1\/KDM1A inhibitors in clinical trials: advances and prospects. J Hematol Oncol. 2019;12(1):129. https:\/\/doi.org\/10.1186\/s13045-019-0811-9.","journal-title":"J Hematol Oncol"},{"key":"477_CR235","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113254","volume":"214","author":"DJ Fu","year":"2021","unstructured":"Fu DJ, Li J, Yu B. Annual review of LSD1\/KDM1A inhibitors in 2020. Eur J Med Chem. 2021;214:113254. https:\/\/doi.org\/10.1016\/j.ejmech.2021.113254.","journal-title":"Eur J Med Chem"},{"issue":"2","key":"477_CR236","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1021\/acs.jmedchem.3c02133","volume":"67","author":"L Shen","year":"2024","unstructured":"Shen L, Wang B, Wang SP, Ji SK, Fu MJ, Wang SW, et al. Combination therapy and dual-target inhibitors based on LSD1: new emerging tools in cancer therapy. J Med Chem. 2024;67(2):922\u201351. https:\/\/doi.org\/10.1021\/acs.jmedchem.3c02133.","journal-title":"J Med Chem"},{"key":"477_CR237","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.114947","volume":"198","author":"B Yuan","year":"2022","unstructured":"Yuan B, Liu H, Pan X, Dong X, Qu LF, Sun J, et al. LSD1 downregulates p21 expression in vascular smooth muscle cells and promotes neointima formation. Biochem Pharmacol. 2022;198:114947. https:\/\/doi.org\/10.1016\/j.bcp.2022.114947.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"477_CR238","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1053\/j.gastro.2022.09.027","volume":"164","author":"H Li","year":"2023","unstructured":"Li H, Zheng J, Xu Q, Yang Y, Zhou J, Guo X, et al. Hepatocyte adenosine kinase promotes excessive fat deposition and liver inflammation. Gastroenterology. 2023;164(1):134\u201346. https:\/\/doi.org\/10.1053\/j.gastro.2022.09.027.","journal-title":"Gastroenterology"},{"key":"477_CR239","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.jare.2024.07.015","volume":"72","author":"T Li","year":"2025","unstructured":"Li T, Li Y, Chen J, Nan M, Zhou X, Yang L, et al. Hyperibone J exerts antidepressant effects by targeting ADK to inhibit microglial P2X7R\/TLR4-mediated neuroinflammation. J Adv Res. 2025;72:571\u201389. https:\/\/doi.org\/10.1016\/j.jare.2024.07.015.","journal-title":"J Adv Res"},{"key":"477_CR240","doi-asserted-by":"publisher","unstructured":"Davila A, Tian Y, Czikora I, A SW, Weinand N, Dong G et al. Adenosine kinase inhibition enhances microvascular dilator function and improves left ventricle diastolic dysfunction. Microcirculation (New York, NY : 1994). 2020;27(6):e12624. https:\/\/doi.org\/10.1111\/micc.12624.","DOI":"10.1111\/micc.12624"},{"key":"477_CR241","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-025-07769-z","author":"J Yan","year":"2025","unstructured":"Yan J, Lin K, Dai S, Zhang Y, Zheng R, Shi S, et al. Class Effect of SGLT2 Inhibitors Against Doxorubicin-Induced Cardiotoxicity via Regulating Adenosine Kinase Mediated-Cardiac Oxidative Stress. Cardiovasc Drugs Ther. 2025. https:\/\/doi.org\/10.1007\/s10557-025-07769-z.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"10","key":"477_CR242","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1093\/cvr\/cvae093","volume":"120","author":"J Xu","year":"2024","unstructured":"Xu J, Liu Z, Yang Q, Ma Q, Zhou Y, Cai Y, et al. Adenosine kinase inhibition protects mice from abdominal aortic aneurysm via epigenetic modulation of VSMC inflammation. Cardiovasc Res. 2024;120(10):1202\u201317. https:\/\/doi.org\/10.1093\/cvr\/cvae093.","journal-title":"Cardiovasc Res"},{"issue":"2","key":"477_CR243","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/cvr\/cvaa040","volume":"117","author":"Y Wang","year":"2021","unstructured":"Wang Y, Xu Y, Yan S, Cao K, Zeng X, Zhou Y, et al. Adenosine kinase is critical for neointima formation after vascular injury by inducing aberrant DNA hypermethylation. Cardiovasc Res. 2021;117(2):561\u201375. https:\/\/doi.org\/10.1093\/cvr\/cvaa040.","journal-title":"Cardiovasc Res"},{"issue":"2","key":"477_CR244","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/cvr\/cvaa122","volume":"117","author":"S Tual-Chalot","year":"2021","unstructured":"Tual-Chalot S, Stellos K. Therapeutic potential of adenosine kinase inhibition in vascular disease. Cardiovasc Res. 2021;117(2):354\u20136. https:\/\/doi.org\/10.1093\/cvr\/cvaa122.","journal-title":"Cardiovasc Res"},{"issue":"11","key":"477_CR245","first-page":"2280","volume":"9","author":"Y He","year":"2019","unstructured":"He Y, Luo Y, Zhang D, Wang X, Zhang P, Li H, et al. PGK1-mediated cancer progression and drug resistance. Am J Cancer Res. 2019;9(11):2280\u2013302.","journal-title":"Am J Cancer Res"},{"key":"477_CR246","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117863","volume":"256","author":"Q Fu","year":"2020","unstructured":"Fu Q, Yu Z. Phosphoglycerate kinase 1 (PGK1) in cancer: a promising target for diagnosis and therapy. Life Sci. 2020;256:117863. https:\/\/doi.org\/10.1016\/j.lfs.2020.117863.","journal-title":"Life Sci"},{"issue":"18","key":"477_CR247","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70242","volume":"13","author":"M Gao","year":"2024","unstructured":"Gao M, Zhu H, Xu H, Jin X, Zheng G, Zhu J, et al. PGK1 can affect the prognosis and development of bladder cancer. Cancer Med. 2024;13(18):e70242. https:\/\/doi.org\/10.1002\/cam4.70242.","journal-title":"Cancer Med"},{"issue":"1","key":"477_CR248","doi-asserted-by":"publisher","DOI":"10.1186\/s13062-023-00448-9","volume":"19","author":"T Tian","year":"2024","unstructured":"Tian T, Leng Y, Tang B, Dong X, Ren Q, Liang J, et al. The oncogenic role and regulatory mechanism of PGK1 in human non-small cell lung cancer. Biol Direct. 2024;19(1):1. https:\/\/doi.org\/10.1186\/s13062-023-00448-9.","journal-title":"Biol Direct"},{"key":"477_CR249","doi-asserted-by":"publisher","unstructured":"Pan CH, Chien YC, Sung MS, Huang HY, Sheu MJ, Wu CH. Pathological Role of Phosphoglycerate Kinase 1 in Balloon Angioplasty-Induced Neointima Formation. Int J Mol Sci. 2021;22(16). https:\/\/doi.org\/10.3390\/ijms22168822.","DOI":"10.3390\/ijms22168822"},{"issue":"7","key":"477_CR250","doi-asserted-by":"publisher","first-page":"5930","DOI":"10.1021\/acsabm.5c00589","volume":"8","author":"P Sun","year":"2025","unstructured":"Sun P, Cui H, Ren C, Xu C, Yue C, Li J, et al. Inhibition of phosphoglycerate kinase 1 (PGK1) decreases neointimal hyperplasia after patch angioplasty. ACS Appl Bio Mater. 2025;8(7):5930\u20137. https:\/\/doi.org\/10.1021\/acsabm.5c00589.","journal-title":"ACS Appl Bio Mater"},{"issue":"11","key":"477_CR251","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1158\/0008-5472.Can-19-2388","volume":"80","author":"H Zhu","year":"2020","unstructured":"Zhu H, Yan F, Yuan T, Qian M, Zhou T, Dai X, et al. USP10 Promotes Proliferation of Hepatocellular Carcinoma by Deubiquitinating and Stabilizing YAP\/TAZ. Can Res. 2020;80(11):2204\u201316. https:\/\/doi.org\/10.1158\/0008-5472.Can-19-2388.","journal-title":"Can Res"},{"key":"477_CR252","doi-asserted-by":"publisher","unstructured":"Tao L, Liu X, Jiang X, Zhang K, Wang Y, Li X et al. USP10 as a Potential Therapeutic Target in Human Cancers. Genes. 2022;13(5). https:\/\/doi.org\/10.3390\/genes13050831.","DOI":"10.3390\/genes13050831"},{"issue":"1","key":"477_CR253","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-022-02266-9","volume":"41","author":"K Guo","year":"2022","unstructured":"Guo K, Ma Z, Zhang Y, Han L, Shao C, Feng Y, et al. HDAC7 promotes NSCLC proliferation and metastasis via stabilization by deubiquitinase USP10 and activation of \u03b2-catenin-FGF18 pathway. J Exp Clin Cancer Res. 2022;41(1):91. https:\/\/doi.org\/10.1186\/s13046-022-02266-9.","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"477_CR254","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.101258","volume":"297","author":"X Xia","year":"2021","unstructured":"Xia X, Liu X, Chai R, Xu Q, Luo Z, Gu J, et al. USP10 exacerbates neointima formation by stabilizing Skp2 protein in vascular smooth muscle cells. J Biol Chem. 2021;297(5):101258. https:\/\/doi.org\/10.1016\/j.jbc.2021.101258.","journal-title":"J Biol Chem"},{"issue":"63","key":"477_CR255","doi-asserted-by":"publisher","first-page":"36649","DOI":"10.1039\/c9ra04726c","volume":"9","author":"H Liu","year":"2019","unstructured":"Liu H, Li X, Yan G, Lun R. Knockdown of USP14 inhibits PDGF-BB-induced vascular smooth muscle cell dedifferentiation via inhibiting mTOR\/P70S6K signaling pathway. RSC Adv. 2019;9(63):36649\u201357. https:\/\/doi.org\/10.1039\/c9ra04726c.","journal-title":"RSC Adv"},{"issue":"1","key":"477_CR256","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-02069-1","volume":"10","author":"X Xia","year":"2024","unstructured":"Xia X, Liu X, Xu Q, Gu J, Ling S, Liu Y, et al. USP14 deficiency inhibits neointima formation following vascular injury via degradation of Skp2 protein. Cell Death Discov. 2024;10(1):295. https:\/\/doi.org\/10.1038\/s41420-024-02069-1.","journal-title":"Cell Death Discov"},{"issue":"6","key":"477_CR257","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s11883-015-0509-6","volume":"17","author":"X Yang","year":"2015","unstructured":"Yang X, Liaw L, Prudovsky I, Brooks PC, Vary C, Oxburgh L, et al. Fibroblast growth factor signaling in the vasculature. Curr Atheroscler Rep. 2015;17(6):509. https:\/\/doi.org\/10.1007\/s11883-015-0509-6.","journal-title":"Curr Atheroscler Rep"},{"issue":"3","key":"477_CR258","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.bbrc.2018.05.049","volume":"501","author":"L Shi","year":"2018","unstructured":"Shi L, Tian C, Sun L, Cao F, Meng Z. The lncRNA TUG1\/miR-145-5p\/FGF10 regulates proliferation and migration in VSMCs of hypertension. Biochem Biophys Res Commun. 2018;501(3):688\u201395. https:\/\/doi.org\/10.1016\/j.bbrc.2018.05.049.","journal-title":"Biochem Biophys Res Commun"},{"key":"477_CR259","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.2147\/jir.S305204","volume":"14","author":"Y Chen","year":"2021","unstructured":"Chen Y, Chen Y, Jiang X, Shi M, Yang Z, Chen Z, et al. Vascular Adventitial Fibroblasts-Derived FGF10 Promotes Vascular Smooth Muscle Cells Proliferation and Migration in vitro and the Neointima Formation in vivo. J Inflamm Res. 2021;14:2207\u201323. https:\/\/doi.org\/10.2147\/jir.S305204.","journal-title":"J Inflamm Res"},{"issue":"8","key":"477_CR260","doi-asserted-by":"publisher","first-page":"5588","DOI":"10.1074\/jbc.M111.328138","volume":"287","author":"W Kim","year":"2012","unstructured":"Kim W, Kim R, Park G, Park JW, Kim JE. Deficiency of H3K79 histone methyltransferase Dot1-like protein (DOT1L) inhibits cell proliferation. J Biol Chem. 2012;287(8):5588\u201399. https:\/\/doi.org\/10.1074\/jbc.M111.328138.","journal-title":"J Biol Chem"},{"issue":"1","key":"477_CR261","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41419-021-04365-5","volume":"13","author":"D Yang","year":"2022","unstructured":"Yang D, Xu P, Su H, Zhong W, Xu J, Su Z, et al. The histone methyltransferase DOT1L is a new epigenetic regulator of pulmonary fibrosis. Cell Death Dis. 2022;13(1):60. https:\/\/doi.org\/10.1038\/s41419-021-04365-5.","journal-title":"Cell Death Dis"},{"issue":"43","key":"477_CR262","doi-asserted-by":"publisher","first-page":"4562","DOI":"10.1093\/eurheartj\/ehac097","volume":"43","author":"FM Farina","year":"2022","unstructured":"Farina FM, Serio S, Hall IF, Zani S, Cassanmagnago GA, Climent M, et al. The epigenetic enzyme DOT1L orchestrates vascular smooth muscle cell-monocyte crosstalk and protects against atherosclerosis via the NF-\u03baB pathway. Eur Heart J. 2022;43(43):4562\u201376. https:\/\/doi.org\/10.1093\/eurheartj\/ehac097.","journal-title":"Eur Heart J"},{"key":"477_CR263","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2023.122245","volume":"301","author":"T Shirasu","year":"2023","unstructured":"Shirasu T, Yodsanit N, Li J, Huang Y, Xie X, Tang R, et al. Neointima abating and endothelium preserving - An adventitia-localized nanoformulation to inhibit the epigenetic writer DOT1L. Biomaterials. 2023;301:122245. https:\/\/doi.org\/10.1016\/j.biomaterials.2023.122245.","journal-title":"Biomaterials"},{"issue":"12","key":"477_CR264","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.1080\/15548627.2021.1911018","volume":"17","author":"C Ouyang","year":"2021","unstructured":"Ouyang C, Li J, Zheng X, Mu J, Torres G, Wang Q, et al. Deletion of Ulk1 inhibits neointima formation by enhancing KAT2A\/GCN5-mediated acetylation of TUBA\/\u03b1-tubulin in vivo. Autophagy. 2021;17(12):4305\u201322. https:\/\/doi.org\/10.1080\/15548627.2021.1911018.","journal-title":"Autophagy"},{"issue":"2","key":"477_CR265","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10571-017-0505-1","volume":"38","author":"L Sun","year":"2018","unstructured":"Sun L, Zhao M, Liu A, Lv M, Zhang J, Li Y, et al. Shear Stress Induces Phenotypic Modulation of Vascular Smooth Muscle Cells via AMPK\/mTOR\/ULK1-Mediated Autophagy. Cell Mol Neurobiol. 2018;38(2):541\u20138. https:\/\/doi.org\/10.1007\/s10571-017-0505-1.","journal-title":"Cell Mol Neurobiol"},{"key":"477_CR266","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2021.108628","volume":"194","author":"Y Fukata","year":"2021","unstructured":"Fukata Y, Hirano Y, Miyazaki Y, Yokoi N, Fukata M. Trans-synaptic LGI1-ADAM22-MAGUK in AMPA and NMDA receptor regulation. Neuropharmacology. 2021;194:108628. https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108628.","journal-title":"Neuropharmacology"},{"issue":"1","key":"477_CR267","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-01806-4","volume":"18","author":"S Charmsaz","year":"2020","unstructured":"Charmsaz S, Doherty B, Cocchiglia S, Vare\u0161lija D, Marino A, Cosgrove N, et al. ADAM22\/LGI1 complex as a new actionable target for breast cancer brain metastasis. BMC Med. 2020;18(1):349. https:\/\/doi.org\/10.1186\/s12916-020-01806-4.","journal-title":"BMC Med"},{"key":"477_CR268","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.atherosclerosis.2019.02.002","volume":"283","author":"SM Zhang","year":"2019","unstructured":"Zhang SM, Jiang L, Zhao X, Liu JF, Liang B, Liu C, et al. A disintegrin and metalloprotease 22 accelerates neointima formation by activating ERK signaling. Atherosclerosis. 2019;283:92\u20139. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.02.002.","journal-title":"Atherosclerosis"},{"issue":"8","key":"477_CR269","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112869","volume":"42","author":"X Xu","year":"2023","unstructured":"Xu X, Zhang DD, Kong P, Gao YK, Huang XF, Song Y, et al. Sox10 escalates vascular inflammation by mediating vascular smooth muscle cell transdifferentiation and pyroptosis in neointimal hyperplasia. Cell Rep. 2023;42(8):112869. https:\/\/doi.org\/10.1016\/j.celrep.2023.112869.","journal-title":"Cell Rep"},{"key":"477_CR270","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/978-3-030-12457-1_9","volume-title":"Advances in experimental medicine and biology","author":"CA Bill","year":"2020","unstructured":"Bill CA, Vines CM. Phospholipase C. In: Advances in experimental medicine and biology, vol. 1131. 2020. p. 215\u201342. https:\/\/doi.org\/10.1007\/978-3-030-12457-1_9."},{"issue":"6","key":"477_CR271","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.jvs.2007.08.013","volume":"46","author":"E Roztocil","year":"2007","unstructured":"Roztocil E, Nicholl SM, Davies MG. Sphingosine-1-phosphate\u2013induced oxygen free radical generation in smooth muscle cell migration requires G\u03b112\/13 protein-mediated phospholipase C activation. J Vasc Surg. 2007;46(6):1253\u20139. https:\/\/doi.org\/10.1016\/j.jvs.2007.08.013.","journal-title":"J Vasc Surg"},{"issue":"7","key":"477_CR272","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1038\/s12276-024-01271-6","volume":"56","author":"SY Jin","year":"2024","unstructured":"Jin SY, Ha JM, Kum HJ, Ma JS, Ha HK, Song SH, et al. Phospholipase C-\u03b23 is dispensable for vascular constriction but indispensable for vascular hyperplasia. Exp Mol Med. 2024;56(7):1620\u201330. https:\/\/doi.org\/10.1038\/s12276-024-01271-6.","journal-title":"Exp Mol Med"},{"issue":"8","key":"477_CR273","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1161\/circresaha.115.306233","volume":"117","author":"LH Dong","year":"2015","unstructured":"Dong LH, Li L, Song Y, Duan ZL, Sun SG, Lin YL, et al. TRAF6-mediated SM22\u03b1 K21 ubiquitination promotes G6PD activation and NADPH production, contributing to GSH homeostasis and VSMC survival in vitro and in vivo. Circ Res. 2015;117(8):684\u201394. https:\/\/doi.org\/10.1161\/circresaha.115.306233.","journal-title":"Circ Res"},{"issue":"1","key":"477_CR274","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s11658-024-00566-w","volume":"29","author":"T Zhang","year":"2024","unstructured":"Zhang T, Cao RJ, Niu JL, Chen ZH, Mu SQ, Cao T, et al. G6PD maintains the VSMC synthetic phenotype and accelerates vascular neointimal hyperplasia by inhibiting the VDAC1-Bax-mediated mitochondrial apoptosis pathway. Cell Mol Biol Lett. 2024;29(1):47. https:\/\/doi.org\/10.1186\/s11658-024-00566-w.","journal-title":"Cell Mol Biol Lett"},{"key":"477_CR275","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.vph.2018.10.006","volume":"114","author":"C Indolfi","year":"2019","unstructured":"Indolfi C, Iaconetti C, Gareri C, Polimeni A, De Rosa S. Non-coding RNAs in vascular remodeling and restenosis. Vasc Pharmacol. 2019;114:49\u201363. https:\/\/doi.org\/10.1016\/j.vph.2018.10.006.","journal-title":"Vasc Pharmacol"},{"issue":"12","key":"477_CR276","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.7150\/ijbs.36995","volume":"15","author":"S Feng","year":"2019","unstructured":"Feng S, Gao L, Zhang D, Tian X, Kong L, Shi H, et al. MiR-93 regulates vascular smooth muscle cell proliferation, and neointimal formation through targeting Mfn2. Int J Biol Sci. 2019;15(12):2615\u201326. https:\/\/doi.org\/10.7150\/ijbs.36995.","journal-title":"Int J Biol Sci"},{"issue":"4","key":"477_CR277","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1620\/tjem.2024.J066","volume":"264","author":"Z Wang","year":"2025","unstructured":"Wang Z, Ma S. Plasma miR-21-5p and miRNA-93-5p levels as early assessment tools for in-stent restenosis following endovascular stenting treatment in patients with lower extremity atherosclerotic disease. Tohoku J Exp Med. 2025;264(4):185\u201392. https:\/\/doi.org\/10.1620\/tjem.2024.J066.","journal-title":"Tohoku J Exp Med"},{"issue":"2","key":"477_CR278","doi-asserted-by":"publisher","first-page":"H377","DOI":"10.1152\/ajpheart.00717.2019","volume":"319","author":"S Lei","year":"2020","unstructured":"Lei S, Peng F, Li ML, Duan WB, Peng CQ, Wu SJ. LncRNA-SMILR modulates RhoA\/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension. Am J Physiol Heart Circ Physiol. 2020;319(2):H377\u201391. https:\/\/doi.org\/10.1152\/ajpheart.00717.2019.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5","key":"477_CR279","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s00018-023-04762-3","volume":"80","author":"L Lyu","year":"2023","unstructured":"Lyu L, Li Z, Wen Z, He Y, Wang X, Jiang L, et al. Fate mapping RNA-sequencing reveal Malat1 regulates Sca1(+) progenitor cells to vascular smooth muscle cells transition in vascular remodeling. Cell Mol Life Sci CMLS. 2023;80(5):118. https:\/\/doi.org\/10.1007\/s00018-023-04762-3.","journal-title":"Cell Mol Life Sci CMLS"},{"key":"477_CR280","doi-asserted-by":"publisher","unstructured":"Yang J, Jiang G, Huang L, Liu Z, Jiang R, Cao G et al. The Long non-coding RNA MALAT1 functions as a competing endogenous RNA to regulate vascular remodeling by sponging miR-145\u20135p\/HK2 in hypertension. Clin Exp Hypertens (New York, NY : 1993). 2023;45(1):2284658. https:\/\/doi.org\/10.1080\/10641963.2023.2284658.","DOI":"10.1080\/10641963.2023.2284658"},{"issue":"2","key":"477_CR281","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/jcpt.13060","volume":"45","author":"L Chen","year":"2020","unstructured":"Chen L, Qu H, Guo M, Zhang Y, Cui Y, Yang Q, et al. ANRIL and atherosclerosis. J Clin Pharm Ther. 2020;45(2):240\u20138. https:\/\/doi.org\/10.1111\/jcpt.13060.","journal-title":"J Clin Pharm Ther"},{"issue":"3","key":"477_CR282","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1161\/atvbaha.122.318367","volume":"43","author":"LM Reolizo","year":"2023","unstructured":"Reolizo LM, Williams H, Wadey K, Frankow A, Li Z, Gaston K, et al. Inhibition of Intimal Thickening By PRH (Proline-Rich Homeodomain) in Mice. Arterioscler Thromb Vasc Biol. 2023;43(3):456\u201373. https:\/\/doi.org\/10.1161\/atvbaha.122.318367.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"477_CR283","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s10456-025-09978-4","volume":"28","author":"S Kant","year":"2025","unstructured":"Kant S, Caliz AD, Yoo HJ, Kaur G, Learnard H, Khalil HA, et al. Mixed lineage kinase (MLK) controls tumor development and angiogenesis. Angiogenesis. 2025;28(3):29. https:\/\/doi.org\/10.1007\/s10456-025-09978-4.","journal-title":"Angiogenesis"},{"issue":"7","key":"477_CR284","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1161\/atvbaha.114.303439","volume":"34","author":"V Gadang","year":"2014","unstructured":"Gadang V, Konaniah E, Hui DY, Jaeschke A. Mixed-lineage kinase 3 deficiency promotes neointima formation through increased activation of the RhoA pathway in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2014;34(7):1429\u201336. https:\/\/doi.org\/10.1161\/atvbaha.114.303439.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"477_CR285","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1161\/circresaha.122.321614","volume":"131","author":"Y Chen","year":"2022","unstructured":"Chen Y, Mao C, Gu R, Zhao R, Li W, Ma Z, et al. Nidogen-2 is a Novel Endogenous Ligand of LGR4 to Inhibit Vascular Calcification. Circ Res. 2022;131(12):1037\u201354. https:\/\/doi.org\/10.1161\/circresaha.122.321614.","journal-title":"Circ Res"},{"issue":"15","key":"477_CR286","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1161\/circulationaha.120.053361","volume":"144","author":"C Mao","year":"2021","unstructured":"Mao C, Ma Z, Jia Y, Li W, Xie N, Zhao G, et al. Nidogen-2 Maintains the Contractile Phenotype of Vascular Smooth Muscle Cells and Prevents Neointima Formation via Bridging Jagged1-Notch3 Signaling. Circulation. 2021;144(15):1244\u201361. https:\/\/doi.org\/10.1161\/circulationaha.120.053361.","journal-title":"Circulation"},{"issue":"1","key":"477_CR287","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s10194-023-01644-8","volume":"24","author":"A Labastida-Ram\u00edrez","year":"2023","unstructured":"Labastida-Ram\u00edrez A, Caronna E, Gollion C, Stanyer E, Dapkute A, Braniste D, et al. Mode and site of action of therapies targeting CGRP signaling. J Headache Pain. 2023;24(1):125. https:\/\/doi.org\/10.1186\/s10194-023-01644-8.","journal-title":"J Headache Pain"},{"issue":"2","key":"477_CR288","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1001\/jamaneurol.2024.4537","volume":"82","author":"S Yang","year":"2025","unstructured":"Yang S, Orlova Y, Park H, Smith SM, Guo Y, Chapin BA, et al. Cardiovascular Safety of Anti-CGRP Monoclonal Antibodies in Older Adults or Adults With Disability With Migraine. JAMA Neurol. 2025;82(2):132\u201341. https:\/\/doi.org\/10.1001\/jamaneurol.2024.4537.","journal-title":"JAMA Neurol"},{"key":"477_CR289","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.yjmcc.2013.02.002","volume":"59","author":"L Yang","year":"2013","unstructured":"Yang L, Sakurai T, Kamiyoshi A, Ichikawa-Shindo Y, Kawate H, Yoshizawa T, et al. Endogenous CGRP protects against neointimal hyperplasia following wire-induced vascular injury. J Mol Cell Cardiol. 2013;59:55\u201366. https:\/\/doi.org\/10.1016\/j.yjmcc.2013.02.002.","journal-title":"J Mol Cell Cardiol"},{"issue":"2","key":"477_CR290","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s11626-019-00429-1","volume":"56","author":"P Chen","year":"2020","unstructured":"Chen P, He F, Liu T, Ma S, Shi B. Construction of calcitonin gene-related peptide-modified mesenchymal stem cells and analysis of their effects on the migration and proliferation of vascular smooth muscle cells. In Vitro Cell Dev Biol Anim. 2020;56(2):181\u201391. https:\/\/doi.org\/10.1007\/s11626-019-00429-1.","journal-title":"In Vitro Cell Dev Biol Anim"},{"issue":"1","key":"477_CR291","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41392-025-02194-y","volume":"10","author":"H Li","year":"2025","unstructured":"Li H, Wu Y, Xiang L, Zhao Q, Liu L, Zhu Z, et al. A20 attenuates oxidized self-DNA-mediated inflammation in acute kidney injury. Signal Transduct Target Ther. 2025;10(1):154. https:\/\/doi.org\/10.1038\/s41392-025-02194-y.","journal-title":"Signal Transduct Target Ther"},{"key":"477_CR292","doi-asserted-by":"publisher","unstructured":"Russo L, Babboni S, Del Turco S, Basta G. A20 and TNIP-3 Reduce NF-\u03baB-Mediated Paracrine Responses to Hypoxia\/Hyperglycemia-Induced Endothelial Senescence. Cells. 2025;14(23). https:\/\/doi.org\/10.3390\/cells14231908.","DOI":"10.3390\/cells14231908"},{"issue":"2","key":"477_CR293","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.atherosclerosis.2010.03.029","volume":"211","author":"SM Damrauer","year":"2010","unstructured":"Damrauer SM, Fisher MD, Wada H, Siracuse JJ, da Silva CG, Moon K, et al. A20 inhibits post-angioplasty restenosis by blocking macrophage trafficking and decreasing adventitial neovascularization. Atherosclerosis. 2010;211(2):404\u20138. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2010.03.029.","journal-title":"Atherosclerosis"},{"key":"477_CR294","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.omtn.2017.06.010","volume":"8","author":"Z Meng","year":"2017","unstructured":"Meng Z, Gao P, Chen L, Peng J, Huang J, Wu M, et al. Artificial Zinc-Finger transcription factor of A20 suppresses restenosis in Sprague Dawley rats after carotid injury via the PPAR\u03b1 pathway. Mol Ther Nucleic Acids. 2017;8:123\u201331. https:\/\/doi.org\/10.1016\/j.omtn.2017.06.010.","journal-title":"Mol Ther Nucleic Acids"},{"key":"477_CR295","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.yjmcc.2024.07.003","volume":"195","author":"W Chen","year":"2024","unstructured":"Chen W, Chen A, Lian G, Yan Y, Liu J, Wu J, et al. Zinc attenuates monocrotaline-induced pulmonary hypertension in rats through upregulation of A20. J Mol Cell Cardiol. 2024;195:24\u201335. https:\/\/doi.org\/10.1016\/j.yjmcc.2024.07.003.","journal-title":"J Mol Cell Cardiol"},{"issue":"2","key":"477_CR296","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2020.111982","volume":"390","author":"M Chen","year":"2020","unstructured":"Chen M, Ding Z, Zhang F, Shen H, Zhu L, Yang H, et al. A20 attenuates hypoxia-induced pulmonary arterial hypertension by inhibiting NF-\u03baB activation and pulmonary artery smooth muscle cell proliferation. Exp Cell Res. 2020;390(2):111982. https:\/\/doi.org\/10.1016\/j.yexcr.2020.111982.","journal-title":"Exp Cell Res"},{"issue":"1","key":"477_CR297","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.atherosclerosis.2012.02.015","volume":"222","author":"H Joung","year":"2012","unstructured":"Joung H, Kwon JS, Kim JR, Shin S, Kang W, Ahn Y, et al. Enhancer of polycomb1 lessens neointima formation by potentiation of myocardin-induced smooth muscle differentiation. Atherosclerosis. 2012;222(1):84\u201391. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2012.02.015.","journal-title":"Atherosclerosis"},{"issue":"24","key":"477_CR298","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1038\/s41388-024-03032-1","volume":"43","author":"E Jin","year":"2024","unstructured":"Jin E, Wang S, Chen D, Wang JP, Zeng Y, Sun R, et al. P4HA2 activates mTOR via hydroxylation and targeting P4HA2-mTOR inhibits lung adenocarcinoma cell growth. Oncogene. 2024;43(24):1813\u201323. https:\/\/doi.org\/10.1038\/s41388-024-03032-1.","journal-title":"Oncogene"},{"key":"477_CR299","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122002","volume":"330","author":"L Wang","year":"2023","unstructured":"Wang L, Liu T, Zheng Y, Zhou J, Hua H, Kong L, et al. P4HA2-induced prolyl hydroxylation of YAP1 restricts vascular smooth muscle cell proliferation and neointima formation. Life Sci. 2023;330:122002. https:\/\/doi.org\/10.1016\/j.lfs.2023.122002.","journal-title":"Life Sci"},{"issue":"6","key":"477_CR300","doi-asserted-by":"publisher","first-page":"C574","DOI":"10.1152\/ajpcell.00275.2012","volume":"304","author":"R Pyla","year":"2013","unstructured":"Pyla R, Poulose N, Jun JY, Segar L. Expression of conventional and novel glucose transporters, GLUT1, -9, -10, and -12, in vascular smooth muscle cells. Am J Physiol Cell Physiol. 2013;304(6):C574\u201389. https:\/\/doi.org\/10.1152\/ajpcell.00275.2012.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"477_CR301","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/hmg\/ddx401","volume":"27","author":"YW Syu","year":"2018","unstructured":"Syu YW, Lai HW, Jiang CL, Tsai HY, Lin CC, Lee YC. GLUT10 maintains the integrity of major arteries through regulation of redox homeostasis and mitochondrial function. Hum Mol Genet. 2018;27(2):307\u201321. https:\/\/doi.org\/10.1093\/hmg\/ddx401.","journal-title":"Hum Mol Genet"},{"key":"477_CR302","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2023.05.001","volume":"260","author":"Q Wu","year":"2023","unstructured":"Wu Q, Hu Z, Wang Z, Che Y, Zhang M, Zheng S, et al. Glut10 restrains neointima formation by promoting SMCs mtDNA demethylation and improving mitochondrial function. Transl Res. 2023;260:1\u201316. https:\/\/doi.org\/10.1016\/j.trsl.2023.05.001.","journal-title":"Transl Res"},{"key":"477_CR303","doi-asserted-by":"publisher","unstructured":"Van Eeckhoutte HP, Donovan C, Kim RY, Conlon TM, Ansari M, Khan H et al. RIPK1 kinase-dependent inflammation and cell death contribute to the pathogenesis of COPD. Eur Respir J. 2023;61(4). https:\/\/doi.org\/10.1183\/13993003.01506-2022.","DOI":"10.1183\/13993003.01506-2022"},{"key":"477_CR304","doi-asserted-by":"publisher","unstructured":"Du J, Wang Z. Regulation of RIPK1 Phosphorylation: Implications for Inflammation, Cell Death, and Therapeutic Interventions. Biomedicines. 2024;12(7). https:\/\/doi.org\/10.3390\/biomedicines12071525.","DOI":"10.3390\/biomedicines12071525"},{"key":"477_CR305","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2024.101988","volume":"87","author":"\u00d6 Veli","year":"2024","unstructured":"Veli \u00d6, Kaya \u00d6, Varanda AB, Hildebrandt X, Xiao P, Estornes Y, et al. RIPK1 is dispensable for cell death regulation in \u03b2-cells during hyperglycemia. Mol Metab. 2024;87:101988. https:\/\/doi.org\/10.1016\/j.molmet.2024.101988.","journal-title":"Mol Metab"},{"issue":"35","key":"477_CR306","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adh8939","volume":"9","author":"Y Lu","year":"2023","unstructured":"Lu Y, Leng Y, Li Y, Wang J, Wang W, Wang R, et al. Endothelial RIPK1 protects artery bypass graft against arteriosclerosis by regulating SMC growth. Sci Adv. 2023;9(35):eadh8939. https:\/\/doi.org\/10.1126\/sciadv.adh8939.","journal-title":"Sci Adv"},{"issue":"1","key":"477_CR307","doi-asserted-by":"publisher","DOI":"10.1080\/02656736.2025.2463477","volume":"42","author":"L Mu","year":"2025","unstructured":"Mu L, Xue S, Tuo W, Wu X, Hou L, Li G. Nec-1 regulates phenotypic transformation of heat stroke-induced vascular smooth muscle cells by inhibiting RIPK1. Int J Hyperthermia. 2025;42(1):2463477. https:\/\/doi.org\/10.1080\/02656736.2025.2463477.","journal-title":"Int J Hyperthermia"},{"issue":"7","key":"477_CR308","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0327669","volume":"20","author":"N Zhou","year":"2025","unstructured":"Zhou N, Wu T, Yu Y, Gao W, Jiang B, Hu H, et al. MTMR7 regulates human spermatogonial stem cells proliferation and migration via targeting FLNB. PLoS ONE. 2025;20(7):e0327669. https:\/\/doi.org\/10.1371\/journal.pone.0327669.","journal-title":"PLoS ONE"},{"issue":"8","key":"477_CR309","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1139\/cjpp-2025-0039","volume":"103","author":"N Dai","year":"2025","unstructured":"Dai N, Groenendyk J, Michalak M. Myotubularin related protein 7, a novel STIM1 binding protein. Can J Physiol Pharmacol. 2025;103(8):276\u201383. https:\/\/doi.org\/10.1139\/cjpp-2025-0039.","journal-title":"Can J Physiol Pharmacol"},{"key":"477_CR310","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2024.117470","volume":"390","author":"X Sun","year":"2024","unstructured":"Sun X, Yang Y, Zhao W, Wang M, Chen Y, Wang J, et al. MTMR7 suppresses the phenotypic switching of vascular smooth muscle cell and vascular intimal hyperplasia after injury via regulating p62\/mTORC1-mediated glucose metabolism. Atherosclerosis. 2024;390:117470. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.117470.","journal-title":"Atherosclerosis"},{"issue":"6","key":"477_CR311","doi-asserted-by":"publisher","first-page":"3799","DOI":"10.1007\/s11010-025-05217-y","volume":"480","author":"J Wang","year":"2025","unstructured":"Wang J, Xuan B, Song B, Wang T, Lan C, Guo W, et al. MTMR7 attenuates the proliferation and migration of pulmonary arterial smooth muscle cells in pulmonary hypertension by suppressing ERK\/STAT3 signaling. Mol Cell Biochem. 2025;480(6):3799\u2013812. https:\/\/doi.org\/10.1007\/s11010-025-05217-y.","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"477_CR312","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.ymthe.2024.12.037","volume":"33","author":"J Rodor","year":"2025","unstructured":"Rodor J, Klimi E, Brown SD, Krilis G, Braga L, Ring NAR, et al. Functional screening identifies miRNAs with a novel function inhibiting vascular smooth muscle cell proliferation. Mol Ther J Am Soc Gene Ther. 2025;33(2):615\u201330. https:\/\/doi.org\/10.1016\/j.ymthe.2024.12.037.","journal-title":"Mol Ther J Am Soc Gene Ther"},{"issue":"1","key":"477_CR313","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-07280-7","volume":"12","author":"J Zhang","year":"2022","unstructured":"Zhang J, Starkuviene V, Erfle H, Wang Z, Gunkel M, Zeng Z, et al. High-content analysis of microRNAs involved in the phenotype regulation of vascular smooth muscle cells. Sci Rep. 2022;12(1):3498. https:\/\/doi.org\/10.1038\/s41598-022-07280-7.","journal-title":"Sci Rep"},{"issue":"17","key":"477_CR314","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1161\/circulationaha.117.027799","volume":"137","author":"F Yang","year":"2018","unstructured":"Yang F, Chen Q, He S, Yang M, Maguire EM, An W, et al. miR-22 is a novel mediator of vascular smooth muscle cell phenotypic modulation and neointima formation. Circulation. 2018;137(17):1824\u201341. https:\/\/doi.org\/10.1161\/circulationaha.117.027799.","journal-title":"Circulation"},{"issue":"17","key":"477_CR315","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1161\/circulationaha.118.033042","volume":"137","author":"ZP Huang","year":"2018","unstructured":"Huang ZP, Wang DZ. miR-22 in smooth muscle cells: a potential therapy for cardiovascular disease. Circulation. 2018;137(17):1842\u20135. https:\/\/doi.org\/10.1161\/circulationaha.118.033042.","journal-title":"Circulation"},{"issue":"13","key":"477_CR316","doi-asserted-by":"publisher","first-page":"3612","DOI":"10.1039\/d2bm00536k","volume":"10","author":"JY Fu","year":"2022","unstructured":"Fu JY, Lai YX, Zheng SS, Wang J, Wang YX, Ren KF, et al. Mir-22-incorporated polyelectrolyte coating prevents intima hyperplasia after balloon-induced vascular injury. Biomaterials science. 2022;10(13):3612\u201323. https:\/\/doi.org\/10.1039\/d2bm00536k.","journal-title":"Biomaterials science"},{"key":"477_CR317","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioadv.2022.213140","volume":"142","author":"SS Zheng","year":"2022","unstructured":"Zheng SS, Zhao J, Chen JW, Shen XH, Hong XL, Fu GS, et al. Inhibition of neointimal hyperplasia in balloon-induced vascular injuries in a rat model by miR-22 loading Laponite hydrogels. Biomater Adv. 2022;142:213140. https:\/\/doi.org\/10.1016\/j.bioadv.2022.213140.","journal-title":"Biomater Adv"},{"issue":"12","key":"477_CR318","doi-asserted-by":"publisher","first-page":"4686","DOI":"10.1016\/j.bioactmat.2021.04.037","volume":"6","author":"J Wang","year":"2021","unstructured":"Wang J, Qian HL, Chen SY, Huang WP, Huang DN, Hao HY, et al. miR-22 eluting cardiovascular stent based on a self-healable spongy coating inhibits in-stent restenosis. Bioactive Mater. 2021;6(12):4686\u201396. https:\/\/doi.org\/10.1016\/j.bioactmat.2021.04.037.","journal-title":"Bioactive Mater"},{"issue":"19","key":"477_CR319","doi-asserted-by":"publisher","first-page":"8046","DOI":"10.18632\/aging.204334","volume":"14","author":"Y Hu","year":"2022","unstructured":"Hu Y, Fan Y, Zhang C, Wang C. Palmitic acid inhibits vascular smooth muscle cell switch to synthetic phenotype via upregulation of miR-22 expression. Aging. 2022;14(19):8046\u201360. https:\/\/doi.org\/10.18632\/aging.204334.","journal-title":"Aging"},{"issue":"1","key":"477_CR320","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1080\/13880209.2020.1781904","volume":"58","author":"M Zhang","year":"2020","unstructured":"Zhang M, Li Y, Xie H, Chen J, Liu S. Curcumin inhibits proliferation, migration and neointimal formation of vascular smooth muscle via activating miR-22. Pharm Biol. 2020;58(1):610\u20139. https:\/\/doi.org\/10.1080\/13880209.2020.1781904.","journal-title":"Pharm Biol"},{"issue":"6","key":"477_CR321","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1536\/ihj.21-829","volume":"63","author":"W Tan","year":"2022","unstructured":"Tan W, Yang Y, Bao H, Kang X, Zeng H, Hong L, et al. MicroRNA-22-3p restraints the proliferation, phenotypic transformation, and migration of vascular smooth muscle cells by manipulating TOMM40. Int Heart J. 2022;63(6):1166\u201375. https:\/\/doi.org\/10.1536\/ihj.21-829.","journal-title":"Int Heart J"},{"issue":"6","key":"477_CR322","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1159\/000480212","volume":"42","author":"SC Huang","year":"2017","unstructured":"Huang SC, Wang M, Wu WB, Wang R, Cui J, Li W, et al. Mir-22-3p inhibits arterial smooth muscle cell proliferation and migration and neointimal hyperplasia by targeting HMGB1 in Arteriosclerosis Obliterans. Cell Physiol Biochem. 2017;42(6):2492\u2013506. https:\/\/doi.org\/10.1159\/000480212.","journal-title":"Cell Physiol Biochem"},{"issue":"10","key":"477_CR323","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1161\/atvbaha.115.305748","volume":"35","author":"F Xu","year":"2015","unstructured":"Xu F, Ahmed AS, Kang X, Hu G, Liu F, Zhang W, et al. MicroRNA-15b\/16 attenuates vascular neointima formation by promoting the contractile phenotype of vascular smooth muscle through targeting YAP. Arterioscler Thromb Vasc Biol. 2015;35(10):2145\u201352. https:\/\/doi.org\/10.1161\/atvbaha.115.305748.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"477_CR324","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1161\/circulationaha.120.049715","volume":"143","author":"Z Zeng","year":"2021","unstructured":"Zeng Z, Xia L, Fan S, Zheng J, Qin J, Fan X, et al. Circular RNA CircMAP3K5 acts as a MicroRNA-22-3p sponge to promote resolution of intimal hyperplasia via TET2-mediated smooth muscle cell differentiation. Circ. 2021;143(4):354\u201371. https:\/\/doi.org\/10.1161\/circulationaha.120.049715.","journal-title":"Circ"},{"issue":"7","key":"477_CR325","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1016\/j.numecd.2021.04.005","volume":"31","author":"X Fu","year":"2021","unstructured":"Fu X, Niu T, Yang T, Li X. CircMAPK1 promotes the proliferation and migration of vascular smooth muscle cells through miR-22-3p\/ methyl-CpG binding protein 2 axis. Nutr Metab Cardiovasc Dis. 2021;31(7):2189\u201398. https:\/\/doi.org\/10.1016\/j.numecd.2021.04.005.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"17","key":"477_CR326","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1161\/circulationaha.114.011675","volume":"130","author":"G Wu","year":"2014","unstructured":"Wu G, Cai J, Han Y, Chen J, Huang ZP, Chen C, et al. LincRNA-p21 regulates neointima formation, vascular smooth muscle cell proliferation, apoptosis, and atherosclerosis by enhancing p53 activity. Circ. 2014;130(17):1452\u201365. https:\/\/doi.org\/10.1161\/circulationaha.114.011675.","journal-title":"Circ"},{"issue":"3","key":"477_CR327","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s12265-020-10074-9","volume":"14","author":"H Wang","year":"2021","unstructured":"Wang H, He F, Liang B, Jing Y, Zhang P, Liu W, et al. p53-dependent LincRNA-p21 protects against proliferation and anti-apoptosis of vascular smooth muscle cells in atherosclerosis by upregulating SIRT7 via MicroRNA-17-5p. J Cardiovasc Transl Res. 2021;14(3):426\u201340. https:\/\/doi.org\/10.1007\/s12265-020-10074-9.","journal-title":"J Cardiovasc Transl Res"},{"issue":"7","key":"477_CR328","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1093\/cvr\/cvae055","volume":"120","author":"K Niu","year":"2024","unstructured":"Niu K, Zhang C, Yang M, Maguire EM, Shi Z, Sun S, et al. Small nucleolar RNA host gene 18 controls vascular smooth muscle cell contractile phenotype and neointimal hyperplasia. Cardiovasc Res. 2024;120(7):796\u2013810. https:\/\/doi.org\/10.1093\/cvr\/cvae055.","journal-title":"Cardiovasc Res"},{"key":"477_CR329","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2023.148027","volume":"895","author":"K Yuce","year":"2024","unstructured":"Yuce K, Ozkan AI. The Kruppel-like factor (KLF) family, diseases, and physiological events. Gene. 2024;895:148027. https:\/\/doi.org\/10.1016\/j.gene.2023.148027.","journal-title":"Gene"},{"issue":"1","key":"477_CR330","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.yexcr.2016.03.001","volume":"342","author":"CJ Nie","year":"2016","unstructured":"Nie CJ, Li YH, Zhang XH, Wang ZP, Jiang W, Zhang Y, et al. SUMOylation of KLF4 acts as a switch in transcriptional programs that control VSMC proliferation. Exp Cell Res. 2016;342(1):20\u201331. https:\/\/doi.org\/10.1016\/j.yexcr.2016.03.001.","journal-title":"Exp Cell Res"},{"key":"477_CR331","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2025.171379","volume":"187","author":"M Zhang","year":"2025","unstructured":"Zhang M, Lei R, Wang L, Jiang Y, Zhou X, Wang Y. KLF4 regulates FAM3A to promotes angiotensin II-induced proliferation and migration of vascular smooth muscle cells through the PI3K\/AKT signaling pathway. Peptides. 2025;187:171379. https:\/\/doi.org\/10.1016\/j.peptides.2025.171379.","journal-title":"Peptides"},{"issue":"1","key":"477_CR332","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/aps.2009.185","volume":"31","author":"Y Liu","year":"2010","unstructured":"Liu Y, Wen JK, Dong LH, Zheng B, Han M. Kr\u00fcppel-like factor (KLF) 5 mediates cyclin D1 expression and cell proliferation via interaction with c-Jun in Ang II-induced VSMCs. Acta Pharmacol Sin. 2010;31(1):10\u20138. https:\/\/doi.org\/10.1038\/aps.2009.185.","journal-title":"Acta Pharmacol Sin"},{"issue":"5","key":"477_CR333","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.31251","volume":"239","author":"X Yuan","year":"2024","unstructured":"Yuan X, Jiang C, Xue Y, Guo F, Luo M, Guo L, et al. KLF13 promotes VSMCs phenotypic dedifferentiation by directly binding to the SM22\u03b1 promoter. J Cell Physiol. 2024;239(5):e31251. https:\/\/doi.org\/10.1002\/jcp.31251.","journal-title":"J Cell Physiol"},{"issue":"8","key":"477_CR334","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1161\/atvbaha.110.207050","volume":"30","author":"Y Lu","year":"2010","unstructured":"Lu Y, Haldar S, Croce K, Wang Y, Sakuma M, Morooka T, et al. Kruppel-like factor 15 regulates smooth muscle response to vascular injury\u2013brief report. Arterioscler Thromb Vasc Biol. 2010;30(8):1550\u20132. https:\/\/doi.org\/10.1161\/atvbaha.110.207050.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"477_CR335","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107260","volume":"300","author":"G Fang","year":"2024","unstructured":"Fang G, Tian Y, Huang S, Zhang X, Liu Y, Li Y, et al. KLF15 maintains contractile phenotype of vascular smooth muscle cells and prevents thoracic aortic dissection by interacting with MRTFB. J Biol Chem. 2024;300(5):107260. https:\/\/doi.org\/10.1016\/j.jbc.2024.107260.","journal-title":"J Biol Chem"},{"key":"477_CR336","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119504","volume":"277","author":"MJ Ramaiah","year":"2021","unstructured":"Ramaiah MJ, Tangutur AD, Manyam RR. Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy. Life Sci. 2021;277:119504. https:\/\/doi.org\/10.1016\/j.lfs.2021.119504.","journal-title":"Life Sci"},{"issue":"4","key":"477_CR337","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1080\/13543776.2020.1725470","volume":"30","author":"C Zhao","year":"2020","unstructured":"Zhao C, Dong H, Xu Q, Zhang Y. Histone deacetylase (HDAC) inhibitors in cancer: a patent review (2017-present). Expert Opin Ther Pat. 2020;30(4):263\u201374. https:\/\/doi.org\/10.1080\/13543776.2020.1725470.","journal-title":"Expert Opin Ther Pat"},{"issue":"6","key":"477_CR338","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2024.101216","volume":"11","author":"H Yang","year":"2024","unstructured":"Yang H, Guo K, Ding P, Ning J, Zhang Y, Wang Y, et al. Histone deacetylases: Regulation of vascular homeostasis via endothelial cells and vascular smooth muscle cells and the role in vascular pathogenesis. Genes Dis. 2024;11(6):101216. https:\/\/doi.org\/10.1016\/j.gendis.2024.101216.","journal-title":"Genes Dis"},{"issue":"6","key":"477_CR339","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1073\/pnas.1121214109","volume":"109","author":"DY Lee","year":"2012","unstructured":"Lee DY, Lee CI, Lin TE, Lim SH, Zhou J, Tseng YC, et al. Role of histone deacetylases in transcription factor regulation and cell cycle modulation in endothelial cells in response to disturbed flow. Proc Natl Acad Sci USA. 2012;109(6):1967\u201372. https:\/\/doi.org\/10.1073\/pnas.1121214109.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"22","key":"477_CR340","doi-asserted-by":"publisher","first-page":"7738","DOI":"10.1073\/pnas.0802857105","volume":"105","author":"S Wang","year":"2008","unstructured":"Wang S, Li X, Parra M, Verdin E, Bassel-Duby R, Olson EN. Control of endothelial cell proliferation and migration by VEGF signaling to histone deacetylase 7. Proc Natl Acad Sci USA. 2008;105(22):7738\u201343. https:\/\/doi.org\/10.1073\/pnas.0802857105.","journal-title":"Proc Natl Acad Sci USA"},{"key":"477_CR341","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.581015","volume":"8","author":"X Chen","year":"2020","unstructured":"Chen X, He Y, Fu W, Sahebkar A, Tan Y, Xu S, et al. Histone Deacetylases (HDACs) and Atherosclerosis: A Mechanistic and Pharmacological Review. Front Cell Dev Biol. 2020;8:581015. https:\/\/doi.org\/10.3389\/fcell.2020.581015.","journal-title":"Front Cell Dev Biol"},{"issue":"7","key":"477_CR342","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jbiomech.2009.01.012","volume":"42","author":"ZQ Yan","year":"2009","unstructured":"Yan ZQ, Yao QP, Zhang ML, Qi YX, Guo ZY, Shen BR, et al. Histone deacetylases modulate vascular smooth muscle cell migration induced by cyclic mechanical strain. J Biomech. 2009;42(7):945\u20138. https:\/\/doi.org\/10.1016\/j.jbiomech.2009.01.012.","journal-title":"J Biomech"},{"issue":"2","key":"477_CR343","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1161\/hypertensionaha.113.01843","volume":"63","author":"T Usui","year":"2014","unstructured":"Usui T, Morita T, Okada M, Yamawaki H. Histone deacetylase 4 controls neointimal hyperplasia via stimulating proliferation and migration of vascular smooth muscle cells. Hypertension (Dallas, Tex\u202f: 1979). 2014;63(2):397\u2013403. https:\/\/doi.org\/10.1161\/hypertensionaha.113.01843.","journal-title":"Hypertension (Dallas, Tex : 1979)"},{"issue":"6","key":"477_CR344","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.jacbts.2018.08.010","volume":"3","author":"M Zhang","year":"2018","unstructured":"Zhang M, Urabe G, Little C, Wang B, Kent AM, Huang Y, et al. HDAC6 Regulates the MRTF-A\/SRF Axis and Vascular Smooth Muscle Cell Plasticity. JACC Basic Transl Sci. 2018;3(6):782\u201395. https:\/\/doi.org\/10.1016\/j.jacbts.2018.08.010.","journal-title":"JACC Basic Transl Sci"},{"issue":"2","key":"477_CR345","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.apsb.2023.11.012","volume":"14","author":"X Zhong","year":"2024","unstructured":"Zhong X, Wei X, Xu Y, Zhu X, Huo B, Guo X, et al. The lysine methyltransferase SMYD2 facilitates neointimal hyperplasia by regulating the HDAC3-SRF axis. Acta Pharm Sin B. 2024;14(2):712\u201328. https:\/\/doi.org\/10.1016\/j.apsb.2023.11.012.","journal-title":"Acta Pharm Sin B"},{"key":"477_CR346","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.exphem.2017.12.012","volume":"60","author":"R Yao","year":"2018","unstructured":"Yao R, Han D, Sun X, Xie Y, Wu Q, Fu C, et al. Scriptaid inhibits cell survival, cell cycle, and promotes apoptosis in multiple myeloma via epigenetic regulation of p21. Exp Hematol. 2018;60:63\u201372. https:\/\/doi.org\/10.1016\/j.exphem.2017.12.012.","journal-title":"Exp Hematol"},{"key":"477_CR347","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20122902","author":"OP Mathew","year":"2019","unstructured":"Mathew OP, Ranganna K, Mathew J, Zhu M, Yousefipour Z, Selvam C, et al. Cellular effects of butyrate on vascular smooth muscle cells are mediated through disparate actions on dual targets, histone deacetylase (HDAC) activity and PI3K\/Akt signaling network. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20122902.","journal-title":"Int J Mol Sci"},{"key":"477_CR348","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115262","volume":"165","author":"P Sun","year":"2023","unstructured":"Sun P, Cui H, Wang S, Zhang Y, Hong S, Wang X, et al. FoxO1 is a negative regulator of neointimal hyperplasia in a rat model of patch angioplasty. Biomed Pharmacother. 2023;165:115262. https:\/\/doi.org\/10.1016\/j.biopha.2023.115262.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"477_CR349","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/cpr.12076","volume":"46","author":"Q Yang","year":"2013","unstructured":"Yang Q, Dahl MJ, Albertine KH, Ramchandran R, Sun M, Raj JU. Role of histone deacetylases in regulation of phenotype of ovine newborn pulmonary arterial smooth muscle cells. Cell Prolif. 2013;46(6):654\u201364. https:\/\/doi.org\/10.1111\/cpr.12076.","journal-title":"Cell Prolif"},{"issue":"5","key":"477_CR350","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1161\/circresaha.111.258426","volume":"110","author":"MA Cavasin","year":"2012","unstructured":"Cavasin MA, Demos-Davies K, Horn TR, Walker LA, Lemon DD, Birdsey N, et al. Selective class I histone deacetylase inhibition suppresses hypoxia-induced cardiopulmonary remodeling through an antiproliferative mechanism. Circ Res. 2012;110(5):739\u201348. https:\/\/doi.org\/10.1161\/circresaha.111.258426.","journal-title":"Circ Res"},{"key":"477_CR351","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116481","volume":"174","author":"M Chen","year":"2024","unstructured":"Chen M, Tan J, Jin Z, Jiang T, Wu J, Yu X. Research progress on sirtuins (SIRTs) family modulators. Biomed Pharmacother. 2024;174:116481. https:\/\/doi.org\/10.1016\/j.biopha.2024.116481.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"477_CR352","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1007\/s10439-013-0957-5","volume":"42","author":"L Wang","year":"2014","unstructured":"Wang L, Han Y, Shen Y, Yan ZQ, Zhang P, Yao QP, et al. Endothelial insulin-like growth factor-1 modulates proliferation and phenotype of smooth muscle cells induced by low shear stress. Ann Biomed Eng. 2014;42(4):776\u201386. https:\/\/doi.org\/10.1007\/s10439-013-0957-5.","journal-title":"Ann Biomed Eng"},{"issue":"12","key":"477_CR353","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1253\/circj.CJ-20-0936","volume":"85","author":"Y Kimura","year":"2021","unstructured":"Kimura Y, Izumiya Y, Araki S, Yamamura S, Hanatani S, Onoue Y, et al. Sirt7 deficiency attenuates neointimal formation following vascular injury by modulating vascular smooth muscle cell proliferation. Circ J. 2021;85(12):2232\u201340. https:\/\/doi.org\/10.1253\/circj.CJ-20-0936.","journal-title":"Circ J"},{"key":"477_CR354","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/4769596","volume":"2018","author":"J Zheng","year":"2018","unstructured":"Zheng J, Chen K, Wang H, Chen Z, Xi Y, Yin H, et al. SIRT7 regulates the vascular smooth muscle cells proliferation and migration via Wnt\/\u03b2-Catenin signaling pathway. Biomed Res Int. 2018;2018:4769596. https:\/\/doi.org\/10.1155\/2018\/4769596.","journal-title":"Biomed Res Int"},{"issue":"3","key":"477_CR355","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.112.000901","volume":"1","author":"Y Tang","year":"2012","unstructured":"Tang Y, Boucher JM, Liaw L. Histone deacetylase activity selectively regulates notch-mediated smooth muscle differentiation in human vascular cells. J Am Heart Assoc. 2012;1(3):e000901. https:\/\/doi.org\/10.1161\/jaha.112.000901.","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"477_CR356","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1161\/circresaha.110.237875","volume":"108","author":"L Li","year":"2011","unstructured":"Li L, Zhang HN, Chen HZ, Gao P, Zhu LH, Li HL, et al. SIRT1 acts as a modulator of neointima formation following vascular injury in mice. Circ Res. 2011;108(10):1180\u20139. https:\/\/doi.org\/10.1161\/circresaha.110.237875.","journal-title":"Circ Res"},{"issue":"4","key":"477_CR357","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s00109-013-1111-4","volume":"92","author":"P Gao","year":"2014","unstructured":"Gao P, Xu TT, Lu J, Li L, Xu J, Hao DL, et al. Overexpression of SIRT1 in vascular smooth muscle cells attenuates angiotensin II-induced vascular remodeling and hypertension in mice. J Mol Med (Berl). 2014;92(4):347\u201357. https:\/\/doi.org\/10.1007\/s00109-013-1111-4.","journal-title":"J Mol Med (Berl)"},{"issue":"6","key":"477_CR358","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1161\/atvbaha.125.322428","volume":"45","author":"M You","year":"2025","unstructured":"You M, Wang B, Li L, Liu M, Wang L, Cao T, et al. SIRT3 represses vascular remodeling via reducing mitochondrial Ac-CoA accumulation in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2025;45(6):985\u20131005. https:\/\/doi.org\/10.1161\/atvbaha.125.322428.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"477_CR359","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/cvr\/cvp263","volume":"85","author":"S Song","year":"2010","unstructured":"Song S, Kang SW, Choi C. Trichostatin A enhances proliferation and migration of vascular smooth muscle cells by downregulating thioredoxin 1. Cardiovasc Res. 2010;85(1):241\u20139. https:\/\/doi.org\/10.1093\/cvr\/cvp263.","journal-title":"Cardiovasc Res"},{"issue":"5-6","key":"477_CR360","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.vph.2011.07.001","volume":"55","author":"HJ Kee","year":"2011","unstructured":"Kee HJ, Kwon JS, Shin S, Ahn Y, Jeong MH, Kook H. Trichostatin A prevents neointimal hyperplasia via activation of Kr\u00fcppel like factor 4. Vasc Pharmacol. 2011;55(5\u20136):127\u201334. https:\/\/doi.org\/10.1016\/j.vph.2011.07.001.","journal-title":"Vasc Pharmacol"},{"key":"477_CR361","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6160","volume":"5","author":"SM Zhang","year":"2014","unstructured":"Zhang SM, Zhu LH, Chen HZ, Zhang R, Zhang P, Jiang DS, et al. Interferon regulatory factor 9 is critical for neointima formation following vascular injury. Nat Commun. 2014;5:5160. https:\/\/doi.org\/10.1038\/ncomms6160.","journal-title":"Nat Commun"},{"issue":"7","key":"477_CR362","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1177\/0271678x18760954","volume":"39","author":"W Wan","year":"2019","unstructured":"Wan W, Ding Y, Xie Z, Li Q, Yan F, Budbazar E, et al. PDGFR-\u03b2 modulates vascular smooth muscle cell phenotype via IRF-9\/SIRT-1\/NF-\u03baB pathway in subarachnoid hemorrhage rats. J Cereb Blood Flow Metab. 2019;39(7):1369\u201380. https:\/\/doi.org\/10.1177\/0271678x18760954.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"12","key":"477_CR363","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1093\/ajh\/hpaa087","volume":"33","author":"W Li","year":"2020","unstructured":"Li W, Deng P, Wang J, Li Z, Zhang H. MiR-17 knockdown promotes vascular smooth muscle cell phenotypic modulation through upregulated interferon regulator factor 9 expression. Am J Hypertens. 2020;33(12):1119\u201326. https:\/\/doi.org\/10.1093\/ajh\/hpaa087.","journal-title":"Am J Hypertens"},{"issue":"5","key":"477_CR364","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.114.001309","volume":"3","author":"L Huang","year":"2014","unstructured":"Huang L, Zhang SM, Zhang P, Zhang XJ, Zhu LH, Chen K, et al. Interferon regulatory factor 7 protects against vascular smooth muscle cell proliferation and neointima formation. J Am Heart Assoc. 2014;3(5):e001309. https:\/\/doi.org\/10.1161\/jaha.114.001309.","journal-title":"J Am Heart Assoc"},{"key":"477_CR365","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118709","volume":"264","author":"Y Deng","year":"2021","unstructured":"Deng Y, Guo SL, Li JQ, Xie SS, Zhou YC, Wei B, et al. Interferon regulatory factor 7 inhibits rat vascular smooth muscle cell proliferation and inflammation in monocrotaline-induced pulmonary hypertension. Life Sci. 2021;264:118709. https:\/\/doi.org\/10.1016\/j.lfs.2020.118709.","journal-title":"Life Sci"},{"issue":"16","key":"477_CR366","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1161\/01.Cir.0000146723.23523.47","volume":"110","author":"I Shiojima","year":"2004","unstructured":"Shiojima I, Walsh K. The role of vascular endothelial growth factor in restenosis: the controversy continues. Circulation. 2004;110(16):2283\u20136. https:\/\/doi.org\/10.1161\/01.Cir.0000146723.23523.47.","journal-title":"Circulation"},{"issue":"4","key":"477_CR367","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1161\/atvbaha.109.183970","volume":"29","author":"M Simons","year":"2009","unstructured":"Simons M. VEGF and restenosis: the rest of the story. Arterioscler Thromb Vasc Biol. 2009;29(4):439\u201340. https:\/\/doi.org\/10.1161\/atvbaha.109.183970.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"477_CR368","doi-asserted-by":"publisher","first-page":"7578","DOI":"10.1021\/acsami.6b00152","volume":"8","author":"X Wu","year":"2016","unstructured":"Wu X, Zhao Y, Tang C, Yin T, Du R, Tian J, et al. Re-Endothelialization Study on Endovascular Stents Seeded by Endothelial Cells through Up- or Downregulation of VEGF. ACS Appl Mater Interfaces. 2016;8(11):7578\u201389. https:\/\/doi.org\/10.1021\/acsami.6b00152.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"6","key":"477_CR369","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1016\/j.biomaterials.2012.11.006","volume":"34","author":"J Yang","year":"2013","unstructured":"Yang J, Zeng Y, Zhang C, Chen YX, Yang Z, Li Y, et al. The prevention of restenosis in vivo with a VEGF gene and paclitaxel co-eluting stent. Biomaterials. 2013;34(6):1635\u201343. https:\/\/doi.org\/10.1016\/j.biomaterials.2012.11.006.","journal-title":"Biomaterials"},{"issue":"9","key":"477_CR370","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0143-9","volume":"50","author":"HK Chang","year":"2018","unstructured":"Chang HK, Kim PH, Kim DW, Cho HM, Jeong MJ, Kim DH, et al. Coronary stents with inducible VEGF\/HGF-secreting UCB-MSCs reduced restenosis and increased re-endothelialization in a swine model. Exp Mol Med. 2018;50(9):1\u201314. https:\/\/doi.org\/10.1038\/s12276-018-0143-9.","journal-title":"Exp Mol Med"},{"key":"477_CR371","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.yjmcc.2024.12.007","volume":"199","author":"JP Hyt\u00f6nen","year":"2025","unstructured":"Hyt\u00f6nen JP, Pajula J, Halonen P, Taavitsainen J, Kuivanen A, Tarvainen S, et al. Endothelialization of coronary stents after intra-luminal adenoviral VEGF-A gene transfer in a preclinical porcine restenosis model - Studies with optical coherence tomography, angioscopy, multiphoton and scanning electron microscopy. J Mol Cell Cardiol. 2025;199:118\u201325. https:\/\/doi.org\/10.1016\/j.yjmcc.2024.12.007.","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"477_CR372","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.jvs.2014.11.068","volume":"63","author":"T Zhang","year":"2016","unstructured":"Zhang T, Qu G. Magnetic nanosphere-guided site-specific delivery of vascular endothelial growth factor gene attenuates restenosis in rabbit balloon-injured artery. J Vasc Surg. 2016;63(1):226-33.e1. https:\/\/doi.org\/10.1016\/j.jvs.2014.11.068.","journal-title":"J Vasc Surg"},{"issue":"1","key":"477_CR373","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3892\/etm.2015.2438","volume":"10","author":"H Xie","year":"2015","unstructured":"Xie H, Yang J, Han Y, Zhu X, Fang Q. Inhibition of intimal hyperplasia via local delivery of vascular endothelial growth factor cDNA nanoparticles in a rabbit model of restenosis induced by abdominal aorta balloon injury. Exp Ther Med. 2015;10(1):55\u201361. https:\/\/doi.org\/10.3892\/etm.2015.2438.","journal-title":"Exp Ther Med"},{"key":"477_CR374","doi-asserted-by":"publisher","first-page":"8730271","DOI":"10.1155\/2017\/8730271","volume":"2017","author":"J Yin","year":"2017","unstructured":"Yin J, Shen L, Ji M, Wu Y, Cai S, Chen J, et al. Inverse Relationship between Serum VEGF Levels and Late In-Stent Restenosis of Drug-Eluting Stents. Biomed Res Int. 2017;2017:8730271. https:\/\/doi.org\/10.1155\/2017\/8730271.","journal-title":"Biomed Res Int"},{"key":"477_CR375","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2023.100832","volume":"23","author":"Y Cui","year":"2023","unstructured":"Cui Y, Jiang X, Yang M, Yuan Y, Zhou Z, Gao X, et al. SEMA4D\/VEGF surface enhances endothelialization by diminished-glycolysis-mediated M2-like macrophage polarization. Mater Today Bio. 2023;23:100832. https:\/\/doi.org\/10.1016\/j.mtbio.2023.100832.","journal-title":"Mater Today Bio"},{"issue":"16","key":"477_CR376","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1161\/01.Cir.0000145123.85083.66","volume":"110","author":"K Ohtani","year":"2004","unstructured":"Ohtani K, Egashira K, Hiasa K, Zhao Q, Kitamoto S, Ishibashi M, et al. Blockade of vascular endothelial growth factor suppresses experimental restenosis after intraluminal injury by inhibiting recruitment of monocyte lineage cells. Circulation. 2004;110(16):2444\u201352. https:\/\/doi.org\/10.1161\/01.Cir.0000145123.85083.66.","journal-title":"Circulation"},{"issue":"17","key":"477_CR377","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202200965","volume":"11","author":"Y Cheng","year":"2022","unstructured":"Cheng Y, Zhang X, Liu R, Li Y, Zeng J, Zhou M, et al. Bioinspired Vascular Stents with Microfluidic Electrospun Multilayer Coatings for Preventing In-Stent Restenosis. Adv Healthcare Mater. 2022;11(17):e2200965. https:\/\/doi.org\/10.1002\/adhm.202200965.","journal-title":"Adv Healthcare Mater"},{"key":"477_CR378","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121654","volume":"287","author":"B Zhang","year":"2022","unstructured":"Zhang B, Qin Y, Yang L, Wan H, Yuan L, Wang Y. An organic selenium and VEGF-conjugated bioinspired coating promotes vascular healing. Biomaterials. 2022;287:121654. https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121654.","journal-title":"Biomaterials"},{"key":"477_CR379","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2021.112068","volume":"208","author":"X Wang","year":"2021","unstructured":"Wang X, Gao B, Ren XK, Guo J, Xia S, Zhang W, et al. A two-pronged approach to regulate the behaviors of ECs and SMCs by the dual targeting-nanoparticles. Colloids Surf B Bioint. 2021;208:112068. https:\/\/doi.org\/10.1016\/j.colsurfb.2021.112068.","journal-title":"Colloids Surf B Bioint"},{"issue":"16","key":"477_CR380","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1161\/01.Cir.0000145138.25577.F1","volume":"110","author":"R Khurana","year":"2004","unstructured":"Khurana R, Zhuang Z, Bhardwaj S, Murakami M, De Muinck E, Yla-Herttuala S, et al. Angiogenesis-dependent and independent phases of intimal hyperplasia. Circulation. 2004;110(16):2436\u201343. https:\/\/doi.org\/10.1161\/01.Cir.0000145138.25577.F1.","journal-title":"Circulation"},{"issue":"11","key":"477_CR381","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/j.1365-2362.2005.01555.x","volume":"35","author":"S Bhardwaj","year":"2005","unstructured":"Bhardwaj S, Roy H, Heikura T, Yl\u00e4-Herttuala S. VEGF-A, VEGF-D and VEGF-D(DeltaNDeltaC) induced intimal hyperplasia in carotid arteries. Eur J Clin Invest. 2005;35(11):669\u201376. https:\/\/doi.org\/10.1111\/j.1365-2362.2005.01555.x.","journal-title":"Eur J Clin Invest"},{"issue":"9","key":"477_CR382","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1007\/s00380-018-1158-9","volume":"33","author":"Z Podemska-Jedrzejczak","year":"2018","unstructured":"Podemska-Jedrzejczak Z, Malinska A, Sujka-Kordowska P, Nowicki M, Puslecki M, Jemielity M, et al. Vascular restenosis in coronary artery bypass grafting might be associated with VEGF-C\/VEGFR-3 signaling pathway. Heart Vessels. 2018;33(9):1106\u201320. https:\/\/doi.org\/10.1007\/s00380-018-1158-9.","journal-title":"Heart Vessels"},{"issue":"2","key":"477_CR383","doi-asserted-by":"publisher","first-page":"224","DOI":"10.4244\/eijv10i2a36","volume":"10","author":"KM Katsaros","year":"2014","unstructured":"Katsaros KM, Kastl SP, Krychtiuk KA, Hutter R, Zorn G, Maurer G, et al. An increase of VEGF plasma levels is associated with restenosis of drug-eluting stents. EuroInterv J EuroPCR Collab Working Group Int Cardiol Eur Soc Cardiol. 2014;10(2):224\u201330. https:\/\/doi.org\/10.4244\/eijv10i2a36.","journal-title":"EuroInterv J EuroPCR Collab Working Group Int Cardiol Eur Soc Cardiol"},{"issue":"3","key":"477_CR384","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s13577-021-00508-0","volume":"34","author":"L Wang","year":"2021","unstructured":"Wang L, Liu J, Lu K, Qiu Y, Li X, Yue F, et al. Long non-coding RNA NEAT1 regulates endothelial functions in subclinical hypothyroidism through miR-126\/TRAF7 pathway. Hum Cell. 2021;34(3):825\u201335. https:\/\/doi.org\/10.1007\/s13577-021-00508-0.","journal-title":"Hum Cell"},{"issue":"5","key":"477_CR385","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.molcel.2017.01.020","volume":"65","author":"AR van Vliet","year":"2017","unstructured":"van Vliet AR, Giordano F, Gerlo S, Segura I, Van Eygen S, Molenberghs G, et al. The ER Stress Sensor PERK Coordinates ER-Plasma Membrane Contact Site Formation through Interaction with Filamin-A and F-Actin Remodeling. Mol Cell. 2017;65(5):885-99.e6. https:\/\/doi.org\/10.1016\/j.molcel.2017.01.020.","journal-title":"Mol Cell"},{"issue":"3","key":"477_CR386","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jacbts.2019.12.005","volume":"5","author":"B Wang","year":"2020","unstructured":"Wang B, Zhang M, Urabe G, Huang Y, Chen G, Wheeler D, et al. PERK Inhibition Mitigates Restenosis and Thrombosis: A Potential Low-Thrombogenic Antirestenotic Paradigm. JACC Basic Transl Sci. 2020;5(3):245\u201363. https:\/\/doi.org\/10.1016\/j.jacbts.2019.12.005.","journal-title":"JACC Basic Transl Sci"},{"key":"477_CR387","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.jss.2020.05.070","volume":"257","author":"B Wang","year":"2021","unstructured":"Wang B, Zhang M, Urabe G, Shirasu T, Guo LW, Kent KC. PERK inhibition promotes post-angioplasty re-endothelialization via modulating SMC phenotype changes. J Surg Res. 2021;257:294\u2013305. https:\/\/doi.org\/10.1016\/j.jss.2020.05.070.","journal-title":"J Surg Res"},{"issue":"8","key":"477_CR388","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2020.165799","volume":"1866","author":"R Zhang","year":"2020","unstructured":"Zhang R, Jiang M, Zhang J, Qiu Y, Li D, Li S, et al. Regulation of the cerebrovascular smooth muscle cell phenotype by mitochondrial oxidative injury and endoplasmic reticulum stress in simulated microgravity rats via the PERK-eIF2\u03b1-ATF4-CHOP pathway. Biochim Biophys Acta Mol Basis Dis. 2020;1866(8):165799. https:\/\/doi.org\/10.1016\/j.bbadis.2020.165799.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"477_CR389","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.abb3616","author":"T Shimizu","year":"2021","unstructured":"Shimizu T, Higashijima Y, Kanki Y, Nakaki R, Kawamura T, Urade Y, et al. PERK inhibition attenuates vascular remodeling in pulmonary arterial hypertension caused by BMPR2 mutation. Sci Signal. 2021. https:\/\/doi.org\/10.1126\/scisignal.abb3616.","journal-title":"Sci Signal"},{"key":"477_CR390","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2025070118","author":"CS Chien","year":"2021","unstructured":"Chien CS, Li JY, Chien Y, Wang ML, Yarmishyn AA, Tsai PH, et al. METTL3-dependent N(6)-methyladenosine RNA modification mediates the atherogenic inflammatory cascades in vascular endothelium. Proc Natl Acad Sci U S A. 2021. https:\/\/doi.org\/10.1073\/pnas.2025070118.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"477_CR391","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119366","volume":"274","author":"Y Qin","year":"2021","unstructured":"Qin Y, Qiao Y, Li L, Luo E, Wang D, Yao Y, et al. The m(6)A methyltransferase METTL3 promotes hypoxic pulmonary arterial hypertension. Life Sci. 2021;274:119366. https:\/\/doi.org\/10.1016\/j.lfs.2021.119366.","journal-title":"Life Sci"},{"issue":"3","key":"477_CR392","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s10557-022-07348-6","volume":"37","author":"J Chen","year":"2023","unstructured":"Chen J, Lai K, Yong X, Yin H, Chen Z, Wang H, et al. Silencing METTL3 stabilizes atherosclerotic plaques by regulating the phenotypic transformation of vascular smooth muscle cells via the miR-375-3p\/PDK1 axis. Cardiovasc Drugs Ther. 2023;37(3):471\u201386. https:\/\/doi.org\/10.1007\/s10557-022-07348-6.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"12","key":"477_CR393","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1161\/atvbaha.124.321399","volume":"44","author":"XF Gao","year":"2024","unstructured":"Gao XF, Chen AQ, Tang HY, Kong XQ, Zhang H, Wang ZM, et al. m(6)A modification of Profilin-1 in vascular smooth muscle cells drives phenotype switching and neointimal hyperplasia via activation of the p-ANXA2\/STAT3 pathway. Arterioscler Thromb Vasc Biol. 2024;44(12):2543\u201359. https:\/\/doi.org\/10.1161\/atvbaha.124.321399.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"477_CR394","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1016\/j.ajpath.2024.08.007","volume":"194","author":"Q Du","year":"2024","unstructured":"Du Q, Zhang C, Qu T, Zhou X, Liu Y, Chen Z, et al. Methyltransferase-Like 3-driven N6-Methyladenosine modification of Recombination Signal Binding Protein for Immunoglobulin Kappa J Region promotes vascular remodeling in pulmonary hypertension. Am J Pathol. 2024;194(12):2252\u201371. https:\/\/doi.org\/10.1016\/j.ajpath.2024.08.007.","journal-title":"Am J Pathol"},{"issue":"4","key":"477_CR395","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13386","volume":"56","author":"ZM Fang","year":"2023","unstructured":"Fang ZM, Zhang SM, Luo H, Jiang DS, Huo B, Zhong X, et al. Methyltransferase-like 3 suppresses phenotypic switching of vascular smooth muscle cells by activating autophagosome formation. Cell Prolif. 2023;56(4):e13386. https:\/\/doi.org\/10.1111\/cpr.13386.","journal-title":"Cell Prolif"},{"issue":"1","key":"477_CR396","doi-asserted-by":"publisher","DOI":"10.1186\/s13008-023-00096-5","volume":"18","author":"H Luo","year":"2023","unstructured":"Luo H, Wu X, Huo B, Liu L, Jiang DS, Yi X. The roles of METTL3 on autophagy and proliferation of vascular smooth muscle cells are mediated by mTOR rather than by CDK1. Cell Div. 2023;18(1):13. https:\/\/doi.org\/10.1186\/s13008-023-00096-5.","journal-title":"Cell Div"},{"issue":"1","key":"477_CR397","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-024-05304-1","volume":"81","author":"K Kang","year":"2024","unstructured":"Kang K, Sun C, Li H, Liu X, Deng J, Chen S, et al. N6-methyladenosine-driven miR-143\/145-KLF4 circuit orchestrates the phenotypic switch of pulmonary artery smooth muscle cells. Cell Mol Life Sci. 2024;81(1):256. https:\/\/doi.org\/10.1007\/s00018-024-05304-1.","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"477_CR398","doi-asserted-by":"publisher","first-page":"173","DOI":"10.11909\/j.issn.1671-5411.2018.02.007","volume":"15","author":"L Pleva","year":"2018","unstructured":"Pleva L, Kukla P, Hlinomaz O. Treatment of coronary in-stent restenosis: a systematic review. J Geriatr Cardiol. 2018;15(2):173\u201384. https:\/\/doi.org\/10.11909\/j.issn.1671-5411.2018.02.007.","journal-title":"J Geriatr Cardiol"},{"key":"477_CR399","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13082377","author":"D Giacoppo","year":"2024","unstructured":"Giacoppo D, Mazzone PM, Capodanno D. Current management of in-stent restenosis. J Clin Med. 2024. https:\/\/doi.org\/10.3390\/jcm13082377.","journal-title":"J Clin Med"},{"key":"477_CR400","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.metabol.2018.12.007","volume":"97","author":"MJ Kim","year":"2019","unstructured":"Kim MJ, Kim MN, Min SH, Ham DS, Kim JW, Yoon KH, et al. Specific PERK inhibitors enhanced glucose-stimulated insulin secretion in a mouse model of type 2 diabetes. Metabolism. 2019;97:87\u201391. https:\/\/doi.org\/10.1016\/j.metabol.2018.12.007.","journal-title":"Metabolism"},{"issue":"23","key":"477_CR401","doi-asserted-by":"publisher","first-page":"4870","DOI":"10.1158\/1078-0432.Ccr-23-1182","volume":"29","author":"ME Stokes","year":"2023","unstructured":"Stokes ME, Calvo V, Fujisawa S, Dudgeon C, Huang S, Ballal N, et al. PERK inhibition by HC-5404 sensitizes renal cell carcinoma tumor models to antiangiogenic tyrosine kinase inhibitors. Clin Cancer Res. 2023;29(23):4870\u201382. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-23-1182.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"477_CR402","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55745-2","volume":"16","author":"F Ji","year":"2025","unstructured":"Ji F, Zhang J, Mao L, Tan Y, Ye M, He X, et al. Liver-specific gene PGRMC1 blocks c-Myc-induced hepatocarcinogenesis through ER stress-independent PERK activation. Nat Commun. 2025;16(1):50. https:\/\/doi.org\/10.1038\/s41467-024-55745-2.","journal-title":"Nat Commun"},{"issue":"8","key":"477_CR403","doi-asserted-by":"publisher","first-page":"779","DOI":"10.14670\/hh-18-211","volume":"35","author":"X Liang","year":"2020","unstructured":"Liang X, Qi Y, Dai F, Gu J, Yao W. PVAT: an important guardian of the cardiovascular system. Histol Histopathol. 2020;35(8):779\u201387. https:\/\/doi.org\/10.14670\/hh-18-211.","journal-title":"Histol Histopathol"},{"key":"477_CR404","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232012156","author":"L Bogdanov","year":"2022","unstructured":"Bogdanov L, Shishkova D, Mukhamadiyarov R, Velikanova E, Tsepokina A, Terekhov A, et al. Excessive adventitial and perivascular vascularisation correlates with vascular inflammation and intimal hyperplasia. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms232012156.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"477_CR405","doi-asserted-by":"publisher","DOI":"10.1007\/s13659-024-00432-4","volume":"14","author":"C Hu","year":"2024","unstructured":"Hu C. Marine natural products and human immunity: novel biomedical resources for anti-infection of SARS-CoV-2 and related cardiovascular disease. Nat Prod Bioprospect. 2024;14(1):12. https:\/\/doi.org\/10.1007\/s13659-024-00432-4.","journal-title":"Nat Prod Bioprospect"},{"key":"477_CR406","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2025.102727","volume":"107","author":"C Hu","year":"2025","unstructured":"Hu C. Prevention of cardiovascular disease for healthy aging and longevity: a new scoring system and related \u201cmechanisms-hallmarks-biomarkers.\u201d Ageing Res Rev. 2025;107:102727. https:\/\/doi.org\/10.1016\/j.arr.2025.102727.","journal-title":"Ageing Res Rev"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00477-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-026-00477-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00477-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T02:23:59Z","timestamp":1779675839000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43556-026-00477-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":406,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["477"],"URL":"https:\/\/doi.org\/10.1186\/s43556-026-00477-6","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"2 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"76"}}